Go to the Table of Contents

Search tables for keyword
Please note: A selected table may take a few minutes to load.

230801
Table 5.1A – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2021 and 2022
Substance Use Disorder Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
DRUGS OR ALCOHOL1 46,787 48,722 2,404 2,228 44,383 46,494 8,764b 9,669 35,619 36,825
DRUGS1 24,467b 27,230 1,896 1,813 22,571b 25,417 5,569b 6,482 17,002a 18,935
Marijuana 16,661b 18,976 1,348 1,308 15,313b 17,669 4,918b 5,740 10,395a 11,928
Cocaine 1,439 1,435 7 6 1,431 1,429 267 268 1,164 1,161
Heroin 990 900 2 2 989 898 67 35 921 864
Hallucinogens 506 592 50 78 456 514 202 228 255 286
Inhalants 354 332 95 70 259 262 90 91 168 171
Methamphetamine 1,628 1,826 23 8 1,604 1,818 121 84 1,483 1,734
Prescription Psychotherapeutics1 7,445 8,227 586 541 6,860 7,687 910 945 5,950 6,742
Pain Relievers1 5,020 5,577 275 265 4,745 5,312 417 410 4,328 4,902
Stimulants1 1,538 1,828 272 259 1,266 1,569 390 476 876 1,093
Tranquilizers or Sedatives1 2,248 2,355 138 135 2,110 2,221 307 290 1,803 1,931
Tranquilizers1 1,710 1,807 103 77 1,607 1,730 251 236 1,356 1,495
Sedatives1 935 833 56 64 879 769 108 81 771 688
Opioids1 5,583 6,117 275 265 5,308 5,852 444 424 4,864 5,427
Central Nervous System Stimulants1 4,214 4,515 283 267 3,932 4,247 647 755 3,285 3,492
ALCOHOL 29,734 29,542 965a 753 28,769 28,788 5,181a 5,689 23,587 23,099
BOTH DRUGS AND ALCOHOL1 7,414 8,049 458 338 6,956 7,712 1,986b 2,502 4,970 5,209
DRUGS ONLY (NO ALCOHOL USE DISORDER)1 17,053b 19,180 1,439 1,475 15,615b 17,706 3,583 3,980 12,032b 13,726
ALCOHOL ONLY (NO DRUG USE DISORDER)1 22,320 21,492 508 415 21,812 21,077 3,195 3,186 18,617 17,890
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.1B – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 12 or Older; by Age Group, Percentages, 2021 and 2022
Substance Use Disorder Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
DRUGS OR ALCOHOL1 16.7 17.3 9.2 8.7 17.5 18.1 26.2 27.8 16.2 16.6
DRUGS1 8.7b 9.7 7.3 7.0 8.9b 9.9 16.6b 18.6 7.7a 8.5
Marijuana 6.0b 6.7 5.2 5.1 6.0b 6.9 14.7a 16.5 4.7a 5.4
Cocaine 0.5 0.5 0.0 0.0 0.6 0.6 0.8 0.8 0.5 0.5
Heroin 0.4 0.3 0.0 0.0 0.4 0.4 0.2 0.1 0.4 0.4
Hallucinogens 0.2 0.2 0.2 0.3 0.2 0.2 0.6 0.7 0.1 0.1
Inhalants 0.1 0.1 0.4 0.3 0.1 0.1 0.3 0.3 0.1 0.1
Methamphetamine 0.6 0.6 0.1 0.0 0.6 0.7 0.4 0.2 0.7 0.8
Prescription Psychotherapeutics1 2.7 2.9 2.3 2.1 2.7 3.0 2.7 2.7 2.7 3.0
Pain Relievers1 1.8 2.0 1.1 1.0 1.9 2.1 1.2 1.2 2.0 2.2
Stimulants1 0.5 0.6 1.0 1.0 0.5 0.6 1.2 1.4 0.4 0.5
Tranquilizers or Sedatives1 0.8 0.8 0.5 0.5 0.8 0.9 0.9 0.8 0.8 0.9
Tranquilizers1 0.6 0.6 0.4 0.3 0.6 0.7 0.7 0.7 0.6 0.7
Sedatives1 0.3 0.3 0.2 0.2 0.3 0.3 0.3 0.2 0.3 0.3
Opioids1 2.0 2.2 1.1 1.0 2.1 2.3 1.3 1.2 2.2 2.5
Central Nervous System Stimulants1 1.5 1.6 1.1 1.0 1.5 1.7 1.9 2.2 1.5 1.6
ALCOHOL 10.6 10.5 3.7a 2.9 11.3 11.2 15.5 16.4 10.7 10.4
BOTH DRUGS AND ALCOHOL1 2.6 2.9 1.8 1.3 2.7 3.0 5.9b 7.2 2.3 2.4
DRUGS ONLY (NO ALCOHOL USE DISORDER)1 6.1b 6.8 5.5 5.7 6.2b 6.9 10.7 11.4 5.5a 6.2
ALCOHOL ONLY (NO DRUG USE DISORDER)1 8.0 7.6 2.0 1.6 8.6 8.2 9.6 9.2 8.4 8.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.2A – Substance Use Disorder Severity Level for Specific Substances in Past Year: Among People Aged 12 or Older; Numbers in Thousands, 2021 and 2022
Substance Any
Substance Use
Disorder
(2021)		 Any
Substance Use
Disorder
(2022)		 Severity Level
Mild
Substance Use
Disorder
(2021)		 Mild
Substance Use
Disorder
(2022)		 Moderate
Substance Use
Disorder
(2021)		 Moderate
Substance Use
Disorder
(2022)		 Severe
Substance Use
Disorder
(2021)		 Severe
Substance Use
Disorder
(2022)
DRUGS OR ALCOHOL1 46,787 48,722 26,535 26,812 10,666 11,025 9,585a 10,886
DRUGS1 24,467b 27,230 13,690a 15,019 5,865 6,403 4,913a 5,809
Marijuana 16,661b 18,976 9,640 10,460 4,350b 5,234 2,671b 3,282
Cocaine 1,439 1,435 627 555 257 209 555 671
Heroin 990 900 263 182 75 169 652 549
Hallucinogens 506 592 312 392 116 122 78 78
Inhalants 354 332 221 257 53 39 80 36
Methamphetamine 1,628 1,826 279 544 392 392 956 890
Prescription Psychotherapeutics1 7,445 8,227 4,740a 5,580 1,508 1,093 1,197 1,554
Pain Relievers1 5,020 5,577 3,269 3,872 974 706 777 999
Stimulants1 1,538 1,828 902a 1,196 330 278 306 353
Tranquilizers or Sedatives1 2,248 2,355 1,329 1,515 504 356 415 485
Tranquilizers1 1,710 1,807 964 1,235 423a 205 323 367
Sedatives1 935 833 590 482 217 183 128 168
Opioids1 5,583 6,117 3,408 3,866 1,024 828 1,151 1,423
Central Nervous System Stimulants1 4,214 4,515 1,632 1,975 936 802 1,646 1,738
ALCOHOL 29,734 29,542 17,660 17,444 6,372 5,968 5,702 6,129
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.2B – Substance Use Disorder Severity Level for Specific Substances in Past Year: Among People Aged 12 or Older; Percentages, 2021 and 2022
Substance Any
Substance Use
Disorder
(2021)		 Any
Substance Use
Disorder
(2022)		 Severity Level
Mild
Substance Use
Disorder
(2021)		 Mild
Substance Use
Disorder
(2022)		 Moderate
Substance Use
Disorder
(2021)		 Moderate
Substance Use
Disorder
(2022)		 Severe
Substance Use
Disorder
(2021)		 Severe
Substance Use
Disorder
(2022)
DRUGS OR ALCOHOL1 16.7 17.3 9.5 9.5 3.8 3.9 3.4a 3.9
DRUGS1 8.7b 9.7 4.9 5.3 2.1 2.3 1.8a 2.1
Marijuana 6.0b 6.7 3.4 3.7 1.6a 1.9 1.0a 1.2
Cocaine 0.5 0.5 0.2 0.2 0.1 0.1 0.2 0.2
Heroin 0.4 0.3 0.1 0.1 0.0 0.1 0.2 0.2
Hallucinogens 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0
Inhalants 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0
Methamphetamine 0.6 0.6 0.1 0.2 0.1 0.1 0.3 0.3
Prescription Psychotherapeutics1 2.7 2.9 1.7 2.0 0.5a 0.4 0.4 0.6
Pain Relievers1 1.8 2.0 1.2 1.4 0.3 0.3 0.3 0.4
Stimulants1 0.5 0.6 0.3a 0.4 0.1 0.1 0.1 0.1
Tranquilizers or Sedatives1 0.8 0.8 0.5 0.5 0.2 0.1 0.1 0.2
Tranquilizers1 0.6 0.6 0.3 0.4 0.2a 0.1 0.1 0.1
Sedatives1 0.3 0.3 0.2 0.2 0.1 0.1 0.0 0.1
Opioids1 2.0 2.2 1.2 1.4 0.4 0.3 0.4 0.5
Central Nervous System Stimulants1 1.5 1.6 0.6 0.7 0.3 0.3 0.6 0.6
ALCOHOL 10.6 10.5 6.3 6.2 2.3 2.1 2.0 2.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.3A – Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021 and 2022
Age Category Drug Use
Disorder1
(2021)		 Drug Use
Disorder1
(2022)		 Alcohol Use
Disorder
(2021)		 Alcohol Use
Disorder
(2022)		 Substance Use
Disorder1
(2021)		 Substance Use
Disorder1
(2022)
TOTAL 24,467b 27,230 29,734 29,542 46,787 48,722
12-202 3,886 4,041 2,233 2,215 4,974 5,188
21 or Older2 20,580b 23,189 27,501 27,326 41,813 43,534
12-17 1,896 1,813 965a 753 2,404 2,228
12-13 260 262 123 96 334 329
14-15 543 639 315a 209 727 746
16-17 1,094 912 528 448 1,343 1,152
18 or Older 22,571b 25,417 28,769 28,788 44,383 46,494
18-25 5,569b 6,482 5,181a 5,689 8,764b 9,669
18-20 1,990 2,228 1,268 1,462 2,570 2,960
21-25 3,578b 4,254 3,914 4,227 6,194 6,709
26 or Older 17,002a 18,935 23,587 23,099 35,619 36,825
26-49 11,289a 12,597 14,691 14,618 22,206 23,186
26-29 2,981 2,911 3,142 3,055 4,976 4,902
30-34 2,685a 3,263 3,542 3,649 5,301 5,666
35-39 2,533 2,479 2,786 3,038 4,531 4,826
40-44 1,656a 2,118 2,864 2,678 3,923 4,146
45-49 1,434 1,826 2,357 2,199 3,474 3,645
50 or Older 5,713 6,338 8,896 8,481 13,413 13,639
50-54 1,351 1,584 1,872 2,485 2,942 3,616
55-59 1,233 1,398 2,232 1,973 3,121 3,081
60-64 1,303 1,523 1,828 1,679 2,938 3,013
65 or Older 1,825 1,833 2,965 2,344 4,412 3,929
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
2 The 12-20 and 21 or Older rows are included because they are the underage and legal age groups for alcohol.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.3B – Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021 and 2022
Age Category Drug Use
Disorder1
(2021)		 Drug Use
Disorder1
(2022)		 Alcohol Use
Disorder
(2021)		 Alcohol Use
Disorder
(2022)		 Substance Use
Disorder1
(2021)		 Substance Use
Disorder1
(2022)
TOTAL 8.7b 9.7 10.6 10.5 16.7 17.3
12-202 9.9 10.5 5.7 5.7 12.7 13.4
21 or Older2 8.5b 9.5 11.4 11.2 17.4 17.9
12-17 7.3 7.0 3.7a 2.9 9.2 8.7
12-13 2.9 3.1 1.4 1.1 3.8 3.9
14-15 6.4 7.1 3.7a 2.3 8.5 8.2
16-17 12.7 11.1 6.1 5.4 15.6 14.0
18 or Older 8.9b 9.9 11.3 11.2 17.5 18.1
18-25 16.6b 18.6 15.5 16.4 26.2 27.8
18-20 15.2 17.2 9.7 11.3 19.7a 22.9
21-25 17.6 19.5 19.2 19.3 30.4 30.7
26 or Older 7.7a 8.5 10.7 10.4 16.2 16.6
26-49 11.0a 12.3 14.4 14.3 21.7 22.6
26-29 17.1 17.1 18.0 17.9 28.5 28.8
30-34 11.8a 14.1 15.6 15.7 23.3 24.4
35-39 11.4 11.2 12.5 13.8 20.4 21.9
40-44 8.1a 10.2 14.0 12.9 19.2 19.9
45-49 7.4 9.4 12.1 11.3 17.8 18.7
50 or Older 4.8 5.3 7.5 7.1 11.4 11.5
50-54 6.9 8.0 9.5 12.6 15.0 18.3
55-59 5.8 7.0 10.5 9.9 14.6 15.4
60-64 5.8 6.7 8.2 7.4 13.2 13.3
65 or Older 3.3 3.2 5.4 4.1 8.0 7.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
2 The 12-20 and 21 or Older rows are included because they are the underage and legal age groups for alcohol.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.4A – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL 24,467b 27,230 1,896 1,813 22,571b 25,417 5,569b 6,482 17,002a 18,935
GENDER                    
Male 13,575a 15,096 872 819 12,703a 14,277 3,030 3,407 9,672 10,871
Female 10,892a 12,134 1,024 994 9,868a 11,140 2,538b 3,075 7,330 8,064
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 20,207b 22,189 1,414 1,270 18,793b 20,919 4,435a 5,001 14,358a 15,918
AIAN 334 253 * 20 304 233 * * 211 174
Asian 540 827 56 46 484 782 148 163 337 619
Black or African American 3,395 3,957 215 285 3,180 3,672 763 863 2,417 2,808
NHOPI 169 * * * * * * * * *
White 14,888 16,056 1,001 845 13,887 15,211 3,211 3,657 10,676 11,554
Two or More Races 882 921 69 68 813 853 191 226 622 627
Hispanic or Latino 4,260a 5,041 482 542 3,778a 4,498 1,134b 1,481 2,644 3,017
EDUCATION LEVEL                    
< High School da da da da 3,079 2,835 667 760 2,412 2,075
High School Graduate da da da da 7,121 7,877 1,919 2,204 5,202 5,673
Some College/Associate’s Degree da da da da 8,462 9,212 2,308 2,617 6,155 6,595
College Graduate da da da da 3,908b 5,494 675a 901 3,233b 4,592
EMPLOYMENT STATUS                    
Full-Time da da da da 8,615b 11,087 2,084b 2,879 6,531b 8,209
Part-Time da da da da 3,456 4,028 1,448 1,637 2,008 2,391
Unemployed da da da da 2,354 2,030 741 689 1,612 1,341
Other1 da da da da 8,146 8,272 1,296 1,277 6,851 6,995
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Drug use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.4B – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL 8.7b 9.7 7.3 7.0 8.9b 9.9 16.6b 18.6 7.7a 8.5
GENDER                    
Male 9.9a 10.9 6.6 6.2 10.3a 11.4 18.1 19.5 9.1 10.1
Female 7.6a 8.4 8.0 7.9 7.6a 8.5 15.2b 17.8 6.5 7.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 8.8a 9.6 7.3 6.7 8.9b 9.9 17.3 18.9 7.8a 8.6
AIAN 18.4 17.3 * 9.2 18.6 18.8 * * 16.1 16.9
Asian 3.3 4.9 3.8 2.8 3.2 5.1 7.6 7.2 2.6 4.7
Black or African American 9.9 11.5 6.1 8.1 10.4 11.9 16.8 18.5 9.3 10.7
NHOPI 14.3 * * * * * * * * *
White 8.7 9.4 7.6 6.6 8.8a 9.6 18.1 20.0 7.6 8.3
Two or More Races 16.1 15.7 7.7 8.1 17.8 16.9 20.6 22.5 17.1 15.5
Hispanic or Latino 8.6 9.9 7.3 8.2 8.8 10.2 14.5a 17.9 7.5 8.4
EDUCATION LEVEL                    
< High School da da da da 10.9 11.6 18.1 21.2 9.8 10.0
High School Graduate da da da da 10.3 11.4 18.2 19.0 8.8 9.9
Some College/Associate’s Degree da da da da 11.0 11.8 16.3a 18.8 9.8 10.3
College Graduate da da da da 4.9b 6.5 13.3 15.8 4.4b 5.8
EMPLOYMENT STATUS                    
Full-Time da da da da 7.5b 9.4 16.4b 20.5 6.4b 7.9
Part-Time da da da da 11.4 12.3 17.7 18.6 9.0 9.9
Unemployed da da da da 18.0 18.4 23.4 21.5 16.3 17.2
Other1 da da da da 8.5 8.8 13.8 14.7 7.9 8.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Drug use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.5A – Marijuana Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL 16,661b 18,976 1,348 1,308 15,313b 17,669 4,918b 5,740 10,395a 11,928
GENDER                    
Male 9,907a 11,033 651 586 9,256a 10,447 2,744 3,077 6,512 7,369
Female 6,754b 7,943 697 721 6,057b 7,222 2,174b 2,663 3,883 4,559
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 13,811a 15,330 1,019 892 12,792b 14,438 3,889a 4,381 8,903a 10,057
AIAN 282a 161 * 17 263a 144 * * 196a 89
Asian 373 560 34 27 338 533 120 141 218 392
Black or African American 2,494 2,772 158 208 2,336 2,564 673 792 1,663 1,772
NHOPI * 113 * * * 107 * * * *
White 9,796a 10,982 722 582 9,074a 10,400 2,829 3,150 6,244a 7,250
Two or More Races 715 742 43 53 672 689 178 210 494 479
Hispanic or Latino 2,850b 3,647 329 416 2,521a 3,231 1,030b 1,359 1,491 1,872
EDUCATION LEVEL                    
< High School da da da da 1,760 1,802 608 671 1,152 1,132
High School Graduate da da da da 4,892a 5,638 1,725 1,988 3,167 3,650
Some College/Associate’s Degree da da da da 6,117 6,451 2,006 2,327 4,111 4,124
College Graduate da da da da 2,544b 3,778 579 755 1,964b 3,023
EMPLOYMENT STATUS                    
Full-Time da da da da 6,623b 8,743 1,871b 2,579 4,752b 6,164
Part-Time da da da da 2,501 2,977 1,236 1,457 1,265 1,521
Unemployed da da da da 1,774 1,501 674 584 1,101 917
Other1 da da da da 4,415 4,448 1,138 1,121 3,277 3,327
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Marijuana use disorder estimates are based on DSM-5 criteria.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.5B – Marijuana Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL 6.0b 6.7 5.2 5.1 6.0b 6.9 14.7a 16.5 4.7a 5.4
GENDER                    
Male 7.2 8.0 4.9 4.5 7.5a 8.4 16.4 17.6 6.1 6.8
Female 4.7b 5.5 5.5 5.7 4.6b 5.5 13.0b 15.4 3.4 4.0
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 6.0a 6.6 5.3 4.7 6.1b 6.8 15.2 16.5 4.8a 5.4
AIAN 15.5 11.0 * 7.6 16.1 11.6 * * 15.0 8.6
Asian 2.3 3.3 2.3 1.7 2.3 3.5 6.2 6.2 1.7 3.0
Black or African American 7.3 8.0 4.5 5.9 7.6 8.3 14.8 17.0 6.4 6.7
NHOPI * 8.9 * * * 8.9 * * * *
White 5.7a 6.4 5.5 4.5 5.7a 6.6 16.0 17.3 4.5a 5.2
Two or More Races 13.1 12.6 4.7 6.4 14.7 13.6 19.3 20.9 13.6 11.8
Hispanic or Latino 5.7a 7.2 5.0 6.3 5.8a 7.3 13.2a 16.5 4.2 5.2
EDUCATION LEVEL                    
< High School da da da da 6.2 7.4 16.5 18.7 4.7 5.4
High School Graduate da da da da 7.1a 8.2 16.4 17.1 5.4 6.3
Some College/Associate’s Degree da da da da 7.9 8.3 14.2a 16.8 6.5 6.5
College Graduate da da da da 3.2b 4.4 11.4 13.3 2.7b 3.8
EMPLOYMENT STATUS                    
Full-Time da da da da 5.8b 7.4 14.7b 18.3 4.7b 5.9
Part-Time da da da da 8.2 9.1 15.1 16.6 5.7 6.3
Unemployed da da da da 13.6 13.6 21.3 18.2 11.1 11.7
Other1 da da da da 4.6 4.7 12.1 12.9 3.8 3.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Marijuana use disorder estimates are based on DSM-5 criteria.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.6A – Prescription Pain Reliever Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL 5,020 5,577 275 265 4,745 5,312 417 410 4,328 4,902
GENDER                    
Male 2,290 2,643 97 109 2,194 2,533 210 187 1,983 2,346
Female 2,729 2,934 178 156 2,551 2,779 206 224 2,345 2,555
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 4,087 4,574 172 182 3,915 4,392 289 333 3,626 4,059
AIAN 82 91 * 1 69 * * * 43 *
Asian 103 186 16 9 88 177 15 6 72 171
Black or African American 737 910 32 52 705 858 67 64 639 794
NHOPI 17 53 * * 17 * * * 8 *
White 3,025 3,175 108 106 2,917 3,069 159 233 2,757 2,836
Two or More Races 124 159 4 14 119 145 13 19 107 126
Hispanic or Latino 933 1,004 103 83 830 920 128 78 702 843
EDUCATION LEVEL                    
< High School da da da da 772 720 54 102 717 619
High School Graduate da da da da 1,722 1,811 184 143 1,538 1,668
Some College/Associate’s Degree da da da da 1,490a 2,009 154 132 1,335a 1,877
College Graduate da da da da 762 771 24 33 737 738
EMPLOYMENT STATUS                    
Full-Time da da da da 1,141 1,337 161 158 980 1,179
Part-Time da da da da 581 621 135 69 446 552
Unemployed da da da da 357 339 37 67 321 272
Other1 da da da da 2,665 3,014 84 117 2,581 2,898
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Prescription pain reliever use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription pain reliever drug use disorder data from all past year users of prescription pain relievers. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.6B – Prescription Pain Reliever Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL 1.8 2.0 1.1 1.0 1.9 2.1 1.2 1.2 2.0 2.2
GENDER                    
Male 1.7 1.9 0.7 0.8 1.8 2.0 1.3 1.1 1.9 2.2
Female 1.9 2.0 1.4 1.2 2.0 2.1 1.2 1.3 2.1 2.2
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.8 2.0 0.9 1.0 1.9 2.1 1.1 1.3 2.0 2.2
AIAN 4.5 6.2 * 0.7 4.2 * * * 3.3 *
Asian 0.6 1.1 1.1 0.5 0.6 1.1 0.8 0.3 0.6 1.3
Black or African American 2.2 2.6 0.9 1.5 2.3 2.8 1.5 1.4 2.4 3.0
NHOPI 1.4 4.2 * * 1.7 * * * 1.0 *
White 1.8 1.9 0.8 0.8 1.8 1.9 0.9 1.3 2.0 2.0
Two or More Races 2.3 2.7 0.5 1.7 2.6 2.9 1.4 1.9 2.9 3.1
Hispanic or Latino 1.9 2.0 1.5 1.3 1.9 2.1 1.6 0.9 2.0 2.3
EDUCATION LEVEL                    
< High School da da da da 2.7 3.0 1.5 2.8 2.9 3.0
High School Graduate da da da da 2.5 2.6 1.7 1.2 2.6 2.9
Some College/Associate’s Degree da da da da 1.9a 2.6 1.1 1.0 2.1a 2.9
College Graduate da da da da 1.0 0.9 0.5 0.6 1.0 0.9
EMPLOYMENT STATUS                    
Full-Time da da da da 1.0 1.1 1.3 1.1 1.0 1.1
Part-Time da da da da 1.9 1.9 1.7 0.8 2.0 2.3
Unemployed da da da da 2.7 3.1 1.2 2.1 3.2 3.5
Other1 da da da da 2.8 3.2 0.9 1.3 3.0 3.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Prescription pain reliever use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription pain reliever drug use disorder data from all past year users of prescription pain relievers. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.7A – Opioid Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL 5,583 6,117 275 265 5,308 5,852 444 424 4,864 5,427
GENDER                    
Male 2,647 3,054 97 109 2,550 2,944 220 198 2,330 2,747
Female 2,936 3,063 178 156 2,758 2,907 224 227 2,534 2,680
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 4,624 5,073 172 182 4,452 4,891 312 345 4,139 4,547
AIAN 93 96 * 1 80 95 * * 54 *
Asian 103 206 16 9 88 197 15 6 72 191
Black or African American 808 1,043 32 52 777 992 67 64 710 928
NHOPI 17 68 * * 17 67 * * 8 *
White 3,466 3,486 108 106 3,357 3,380 182 243 3,175 3,138
Two or More Races 138 174 4 14 133 161 13 21 121 140
Hispanic or Latino 959 1,043 103 83 856 960 131 79 725 881
EDUCATION LEVEL                    
< High School da da da da 935 831 58 103 877 728
High School Graduate da da da da 1,925 2,007 195 149 1,730 1,858
Some College/Associate’s Degree da da da da 1,670a 2,205 166 139 1,504a 2,065
College Graduate da da da da 778 809 25 33 753 776
EMPLOYMENT STATUS                    
Full-Time da da da da 1,247 1,459 167 160 1,080 1,299
Part-Time da da da da 676 659 135 72 540 587
Unemployed da da da da 485 449 44 73 441 375
Other1 da da da da 2,901 3,285 97 119 2,804 3,166
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Opioid use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include opioid use disorder data from all past year users of opioids. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.7B – Opioid Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL 2.0 2.2 1.1 1.0 2.1 2.3 1.3 1.2 2.2 2.5
GENDER                    
Male 1.9 2.2 0.7 0.8 2.1 2.4 1.3 1.1 2.2 2.6
Female 2.1 2.1 1.4 1.2 2.1 2.2 1.3 1.3 2.2 2.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 2.0 2.2 0.9 1.0 2.1 2.3 1.2 1.3 2.2 2.5
AIAN 5.1 6.6 * 0.7 4.9 7.6 * * 4.1 *
Asian 0.6 1.2 1.1 0.5 0.6 1.3 0.8 0.3 0.6 1.5
Black or African American 2.4 3.0 0.9 1.5 2.5 3.2 1.5 1.4 2.7 3.5
NHOPI 1.4 5.3 * * 1.7 5.6 * * 1.0 *
White 2.0 2.0 0.8 0.8 2.1 2.1 1.0 1.3 2.3 2.2
Two or More Races 2.5 3.0 0.5 1.7 2.9 3.2 1.4 2.1 3.3 3.5
Hispanic or Latino 1.9 2.0 1.5 1.3 2.0 2.2 1.7 1.0 2.1 2.4
EDUCATION LEVEL                    
< High School da da da da 3.3 3.4 1.6 2.9 3.6 3.5
High School Graduate da da da da 2.8 2.9 1.9 1.3 2.9 3.2
Some College/Associate’s Degree da da da da 2.2a 2.8 1.2 1.0 2.4a 3.2
College Graduate da da da da 1.0 1.0 0.5 0.6 1.0 1.0
EMPLOYMENT STATUS                    
Full-Time da da da da 1.1 1.2 1.3 1.1 1.1 1.2
Part-Time da da da da 2.2 2.0 1.7 0.8 2.4 2.4
Unemployed da da da da 3.7 4.1 1.4 2.3 4.4 4.8
Other1 da da da da 3.0 3.5 1.0 1.4 3.2 3.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Opioid use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include opioid use disorder data from all past year users of opioids. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.8A – Central Nervous System Stimulant Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL 4,214 4,515 283 267 3,932 4,247 647 755 3,285 3,492
GENDER                    
Male 2,508 2,765 156 139 2,351 2,626 308 380 2,043 2,245
Female 1,707 1,750 126 128 1,580 1,622 339 375 1,242 1,247
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3,388 3,724 229 221 3,159 3,503 566 591 2,593 2,912
AIAN 42 30 * * 41 28 14 * 27 22
Asian 78 134 * 5 72 129 18 30 54 99
Black or African American 390 402 24 29 366 372 19 49 348 323
NHOPI 9 * * * * * * * * *
White 2,719 2,936 175 171 2,544 2,765 482 493 2,061 2,272
Two or More Races 150 135 24 13 127 121 24 12 103 109
Hispanic or Latino 826 791 54 46 773 745 81a 164 692 581
EDUCATION LEVEL                    
< High School da da da da 671 654 75 111 596 542
High School Graduate da da da da 1,133 1,177 179 193 953 984
Some College/Associate’s Degree da da da da 1,569 1,654 301 301 1,267 1,353
College Graduate da da da da 559 763 91 150 468 613
EMPLOYMENT STATUS                    
Full-Time da da da da 1,334 1,690 237 349 1,097 1,341
Part-Time da da da da 535 633 165 159 370 474
Unemployed da da da da 575 550 98 98 477 452
Other1 da da da da 1,488 1,374 147 149 1,340 1,225
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Central nervous system stimulant use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include central nervous system stimulant use disorder data from all past year users of central nervous system stimulants. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.8B – Central Nervous System Stimulant Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL 1.5 1.6 1.1 1.0 1.5 1.7 1.9 2.2 1.5 1.6
GENDER                    
Male 1.8 2.0 1.2 1.1 1.9 2.1 1.8 2.2 1.9 2.1
Female 1.2 1.2 1.0 1.0 1.2 1.2 2.0 2.2 1.1 1.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.5 1.6 1.2 1.2 1.5 1.7 2.2 2.2 1.4 1.6
AIAN 2.3 2.1 * * 2.5 2.2 4.1 * 2.1 2.2
Asian 0.5 0.8 * 0.3 0.5 0.8 0.9 1.3 0.4 0.8
Black or African American 1.1 1.2 0.7 0.8 1.2 1.2 0.4 1.1 1.3 1.2
NHOPI 0.8 * * * * * * * * *
White 1.6 1.7 1.3 1.3 1.6 1.7 2.7 2.7 1.5 1.6
Two or More Races 2.8 2.3 2.6 1.6 2.8 2.4 2.6 1.2 2.8 2.7
Hispanic or Latino 1.7 1.6 0.8 0.7 1.8 1.7 1.0a 2.0 2.0 1.6
EDUCATION LEVEL                    
< High School da da da da 2.4 2.7 2.0 3.1 2.4 2.6
High School Graduate da da da da 1.6 1.7 1.7 1.7 1.6 1.7
Some College/Associate’s Degree da da da da 2.0 2.1 2.1 2.2 2.0 2.1
College Graduate da da da da 0.7 0.9 1.8 2.6 0.6 0.8
EMPLOYMENT STATUS                    
Full-Time da da da da 1.2 1.4 1.9 2.5 1.1 1.3
Part-Time da da da da 1.8 1.9 2.0 1.8 1.7 2.0
Unemployed da da da da 4.4 5.0 3.1 3.0 4.8 5.8
Other1 da da da da 1.5 1.5 1.6 1.7 1.5 1.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Central nervous system stimulant use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include central nervous system stimulant use disorder data from all past year users of central nervous system stimulants. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.9A – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)		 Aged 12-201
(2021)		 Aged 12-201
(2022)		 Aged 21+1
(2021)		 Aged 21+1
(2022)
TOTAL 29,734 29,542 965a 753 28,769 28,788 5,181a 5,689 23,587 23,099 2,233 2,215 27,501 27,326
GENDER                            
Male 16,531 17,351 320 281 16,212 17,070 2,577a 2,984 13,634 14,085 816 1,033 15,715 16,318
Female 13,203 12,191 646a 472 12,557 11,719 2,604 2,705 9,953 9,014 1,417 1,182 11,786 11,009
HISPANIC ORIGIN AND RACE                            
Not Hispanic or Latino 24,635 24,055 725a 528 23,911 23,527 4,134 4,317 19,777 19,210 1,726 1,659 22,910 22,396
AIAN 289a 154 * 10 277a 143 * 29 159 114 * 23 233a 131
Asian 1,041 958 * 28 1,016 929 204 199 812 730 68 62 972 896
Black or African American 3,416 3,609 48 55 3,368 3,555 540 532 2,828 3,023 164 173 3,252 3,436
NHOPI 171 * * * 138 * * * * * * * * *
White 18,894 18,582 568a 406 18,325 18,176 3,131 3,365 15,195 14,811 1,327 1,297 17,567 17,285
Two or More Races 824 609 38 29 786 580 130 158 656 422 75 103 749 506
Hispanic or Latino 5,099 5,486 241 225 4,858 5,261 1,048b 1,372 3,810 3,889 507 556 4,591 4,930
EDUCATION LEVEL                            
< High School da da da da 2,677 2,322 353 447 2,324 1,876 da da 2,482 2,082
High School Graduate da da da da 7,576 6,999 1,422 1,641 6,154 5,358 da da 7,023 6,385
Some College/Associate’s Degree da da da da 9,325 9,608 2,393 2,378 6,932 7,230 da da 8,805 9,001
College Graduate da da da da 9,191 9,859 1,013 1,223 8,178 8,636 da da 9,191 9,858
EMPLOYMENT STATUS                            
Full-Time da da da da 15,211a 16,682 2,377a 2,819 12,834 13,863 da da 14,828 16,141
Part-Time da da da da 3,901 4,050 1,201 1,357 2,701 2,693 da da 3,513 3,549
Unemployed da da da da 2,067 1,704 533 473 1,534 1,231 da da 1,901 1,571
Other2 da da da da 7,590a 6,352 1,071 1,039 6,519a 5,313 da da 7,259a 6,065
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Alcohol use disorder (AUD) estimates are based on DSM-5 criteria.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 The Aged 12-20 and Aged 21+ columns are included because they are the underage and legal age groups for alcohol.
2 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.9B – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)		 Aged 12-201
(2021)		 Aged 12-201
(2022)		 Aged 21+1
(2021)		 Aged 21+1
(2022)
TOTAL 10.6 10.5 3.7a 2.9 11.3 11.2 15.5 16.4 10.7 10.4 5.7 5.7 11.4 11.2
GENDER                            
Male 12.1 12.6 2.4 2.1 13.1 13.6 15.4 17.1 12.8 13.1 4.1a 5.2 13.5 13.8
Female 9.2 8.5 5.1a 3.8 9.6 8.9 15.6 15.6 8.8 7.9 7.4 6.3 9.5 8.8
HISPANIC ORIGIN AND RACE                            
Not Hispanic or Latino 10.7 10.4 3.7a 2.8 11.3 11.1 16.1 16.3 10.7 10.4 6.0 5.8 11.4 11.1
AIAN 15.9 10.5 * 4.7 16.9 11.5 * 14.0 12.2 11.0 * 7.1 15.1 11.5
Asian 6.4 5.6 * 1.8 6.8 6.0 10.4 8.8 6.3 5.6 3.1 2.5 6.9 6.1
Black or African American 10.0 10.5 1.4 1.6 11.0 11.5 11.9 11.4 10.8 11.5 3.1 3.3 11.3 11.8
NHOPI 14.6 * * * 13.7 * * * * * * * * *
White 11.0 10.9 4.3a 3.2 11.6 11.5 17.7 18.4 10.8 10.6 6.8 6.7 11.6 11.4
Two or More Races 15.1a 10.4 4.2 3.5 17.2a 11.5 14.0 15.7 18.0a 10.4 5.6 8.0 18.1a 11.0
Hispanic or Latino 10.2 10.8 3.6 3.4 11.3 11.9 13.4a 16.6 10.8 10.8 5.0 5.6 11.6 12.0
EDUCATION LEVEL                            
< High School da da da da 9.5 9.5 9.6 12.5 9.5 9.0 da da 9.6 9.4
High School Graduate da da da da 10.9 10.1 13.5 14.1 10.5 9.3 da da 11.0 10.1
Some College/Associate’s Degree da da da da 12.1 12.4 16.9 17.1 11.0 11.3 da da 12.3 12.3
College Graduate da da da da 11.6 11.6 19.9 21.5 11.1 10.9 da da 11.6 11.6
EMPLOYMENT STATUS                            
Full-Time da da da da 13.3 14.1 18.7 20.0 12.6 13.3 da da 13.3 14.1
Part-Time da da da da 12.8 12.3 14.7 15.4 12.2 11.2 da da 13.3 12.4
Unemployed da da da da 15.8 15.5 16.8 14.7 15.5 15.8 da da 16.3 16.2
Other2 da da da da 7.9a 6.8 11.4 11.9 7.5a 6.2 da da 7.9a 6.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Alcohol use disorder (AUD) estimates are based on DSM-5 criteria.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 The Aged 12-20 and Aged 21+ columns are included because they are the underage and legal age groups for alcohol.
2 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.10A – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL 46,787 48,722 2,404 2,228 44,383 46,494 8,764b 9,669 35,619 36,825
GENDER                    
Male 26,078 27,658 1,039 980 25,039 26,678 4,671 5,051 20,368 21,627
Female 20,709 21,064 1,365 1,249 19,344 19,816 4,093a 4,618 15,251 15,198
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 38,909 39,841 1,780 1,561 37,129 38,280 6,950 7,408 30,179 30,872
AIAN 512 351 * 27 479 324 * * 328 245
Asian 1,352 1,532 57 58 1,295 1,475 292 297 1,003 1,178
Black or African American 5,771 6,324 241 313 5,530 6,011 1,091 1,114 4,439 4,897
NHOPI 250 * * * * * * * * *
White 29,568 30,071 1,315 1,074 28,253 28,997 5,108 5,576 23,144 23,421
Two or More Races 1,456 1,280 89 84 1,367 1,196 274 302 1,093 894
Hispanic or Latino 7,878 8,881 624 667 7,254 8,214 1,814b 2,261 5,440 5,953
EDUCATION LEVEL                    
< High School da da da da 5,035 4,332 860 955 4,175a 3,377
High School Graduate da da da da 12,333 12,642 2,696 3,067 9,638 9,575
Some College/Associate’s Degree da da da da 15,252 15,865 3,839 3,955 11,413 11,910
College Graduate da da da da 11,763b 13,655 1,369a 1,692 10,393a 11,963
EMPLOYMENT STATUS                    
Full-Time da da da da 20,809b 23,825 3,718b 4,486 17,091b 19,339
Part-Time da da da da 6,218 6,744 2,147 2,403 4,072 4,341
Unemployed da da da da 3,564 3,070 976 908 2,588 2,162
Other1 da da da da 13,792 12,855 1,923 1,872 11,868 10,983
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.10B – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL 16.7 17.3 9.2 8.7 17.5 18.1 26.2 27.8 16.2 16.6
GENDER                    
Male 19.1 20.0 7.8 7.4 20.3 21.3 27.9 28.9 19.1 20.1
Female 14.5 14.7 10.7 9.9 14.8 15.1 24.5 26.7 13.4 13.3
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 16.9 17.2 9.2 8.2 17.6 18.1 27.1 27.9 16.3 16.6
AIAN 28.2 24.0 * 12.1 29.2 26.1 * * 25.1 23.8
Asian 8.3 9.0 3.9 3.6 8.7 9.6 15.0 13.1 7.7 9.0
Black or African American 16.9 18.4 6.8 8.9 18.1 19.4 24.1 23.9 17.0 18.6
NHOPI 21.2 * * * * * * * * *
White 17.3 17.6 10.0 8.4 17.9 18.3 28.8 30.5 16.5 16.7
Two or More Races 26.6 21.8 9.9 10.1 29.9 23.7 29.6 30.1 30.0a 22.1
Hispanic or Latino 15.8 17.4 9.4 10.0 16.8 18.6 23.2a 27.4 15.4 16.5
EDUCATION LEVEL                    
< High School da da da da 17.8 17.8 23.3 26.6 17.0 16.3
High School Graduate da da da da 17.8 18.3 25.6 26.4 16.4 16.6
Some College/Associate’s Degree da da da da 19.8 20.4 27.1 28.5 18.1 18.6
College Graduate da da da da 14.9 16.1 27.0 29.7 14.1 15.1
EMPLOYMENT STATUS                    
Full-Time da da da da 18.2b 20.1 29.2 31.9 16.8b 18.5
Part-Time da da da da 20.5 20.5 26.3 27.3 18.3 18.1
Unemployed da da da da 27.2 27.9 30.8 28.3 26.1 27.7
Other1 da da da da 14.4 13.7 20.4 21.5 13.7 12.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.11A – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL 24,467b 27,230 1,896 1,813 22,571b 25,417 5,569b 6,482 17,002a 18,935
GEOGRAPHIC REGION                    
Northeast 3,951 4,324 274 221 3,677 4,103 960 1,025 2,717 3,079
Midwest 5,587 5,746 501 381 5,086 5,364 1,222 1,391 3,864 3,973
South 8,563a 9,563 600 702 7,963 8,861 1,877b 2,263 6,086 6,598
West 6,366b 7,597 520 508 5,846b 7,088 1,510 1,803 4,335a 5,285
COUNTY TYPE                    
Large Metro 13,028a 14,733 899 997 12,129a 13,736 2,918b 3,535 9,211 10,202
Small Metro 7,507b 9,165 721 665 6,786b 8,499 1,894a 2,292 4,892b 6,208
Nonmetro 3,932 3,332 276a 151 3,656 3,181 757 656 2,899 2,526
Urbanized 1,335 1,490 121 82 1,214 1,407 327 322 887 1,086
Less Urbanized 2,174a 1,541 140a 47 2,034 1,494 395 316 1,639 1,178
Completely Rural 423 301 15 * 408 280 35 18 373 262
POVERTY LEVEL1                    
Less Than 100% 5,480 5,919 420 341 5,060 5,578 1,357 1,484 3,703 4,094
100-199% 6,322 6,771 389 512 5,934 6,259 1,424b 1,828 4,510 4,431
200% or More 12,659b 14,540 1,087 960 11,572b 13,580 2,783 3,169 8,789b 10,410
HEALTH INSURANCE2                    
Private 10,713b 12,938 914 884 9,799b 12,054 3,012b 3,631 6,787b 8,423
Medicaid/CHIP 8,558 9,578 924 876 7,635a 8,702 1,532a 1,886 6,102 6,816
Other3 4,862 5,374 53a 109 4,809 5,266 459 524 4,350 4,742
No Coverage 3,483 2,984 123 55 3,359 2,929 818 756 2,542 2,173
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Drug use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.11B – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL 8.7b 9.7 7.3 7.0 8.9b 9.9 16.6b 18.6 7.7a 8.5
GEOGRAPHIC REGION                    
Northeast 8.1 8.8 6.6 5.4 8.2 9.1 16.8 17.3 7.0 7.9
Midwest 9.6 9.9 9.1 7.1 9.7 10.2 17.2 19.1 8.5 8.7
South 8.0 8.8 5.9 6.9 8.3 9.0 14.8a 17.0 7.3 7.8
West 9.6a 11.4 8.3 8.3 9.7a 11.7 19.0 21.9 8.3a 10.1
COUNTY TYPE                    
Large Metro 8.6 9.4 6.4 6.7 8.9 9.7 16.5 18.5 7.7 8.4
Small Metro 8.8b 10.3 9.0 8.3 8.7b 10.4 17.3 19.6 7.3b 8.9
Nonmetro 9.1 9.1 6.9 5.1 9.3 9.4 15.6 16.5 8.4 8.5
Urbanized 8.3 9.6 8.0 6.6 8.3 9.9 16.2 18.3 7.0 8.7
Less Urbanized 9.6 8.4 6.8a 3.3 9.9 8.8 16.8 16.1 9.0 7.8
Completely Rural 9.3 10.6 3.7 * 9.8 10.9 7.5 7.0 10.1 11.3
POVERTY LEVEL1                    
Less Than 100% 12.6 14.3 7.7 6.5 13.4a 15.4 16.0 18.4 12.6 14.5
100-199% 11.2 12.2 6.9 8.8 11.7 12.6 17.8a 21.6 10.5 10.7
200% or More 7.0a 7.9 7.3 6.5 7.0a 8.0 16.5 17.4 5.9a 6.8
HEALTH INSURANCE2                    
Private 6.4b 7.6 6.6 6.3 6.3b 7.7 15.9a 18.3 5.0b 6.2
Medicaid/CHIP 14.7a 16.3 8.5 8.2 16.1a 18.1 17.6 20.3 15.7 17.6
Other3 6.3 6.9 3.8 7.2 6.4 6.9 18.0 18.7 6.0 6.4
No Coverage 13.3 12.3 9.3 5.5 13.5 12.6 17.0 16.3 12.7 11.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Drug use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.12A – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic
Characteristic		 Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)		 Aged 12-201
(2021)		 Aged 12-201
(2022)		 Aged 21+1
(2021)		 Aged 21+1
(2022)
TOTAL 29,734 29,542 965a 753 28,769 28,788 5,181a 5,689 23,587 23,099 2,233 2,215 27,501 27,326
GEOGRAPHIC REGION                    
Northeast 5,318 5,167 170 113 5,149 5,053 843 995 4,305 4,058 357 385 4,962 4,782
Midwest 6,144 6,405 215 137 5,929 6,268 1,081 1,227 4,848 5,042 505 480 5,639 5,925
South 10,651 10,049 322 302 10,329 9,746 1,907 1,888 8,422 7,858 794 795 9,857 9,254
West 7,621 7,921 259 200 7,362 7,720 1,350 1,578 6,012 6,142 577 556 7,044 7,365
COUNTY TYPE                            
Large Metro 16,377 16,720 501 393 15,876 16,326 2,732 3,092 13,144 13,234 1,211 1,131 15,166 15,589
Small Metro 9,311 9,559 322 257 8,989 9,301 1,740 1,946 7,249 7,355 741 783 8,570 8,775
Nonmetro 4,046a 3,263 142 103 3,904a 3,161 709 651 3,195a 2,510 280 301 3,766a 2,963
Urbanized 1,681 1,446 79 40 1,602 1,406 309 274 1,294 1,132 143 128 1,538 1,318
Less Urbanized 1,965 1,605 60 48 1,906 1,557 321 351 1,584 1,206 118 152 1,847 1,453
Completely Rural 400 212 4 * 396 197 79 * 317 172 19 * 381 191
POVERTY LEVEL2                            
Less Than 100% 4,493 4,375 214 140 4,279 4,235 1,246 1,319 3,033 2,915 644 536 3,849 3,839
100-199% 5,681 5,252 157 176 5,524 5,076 1,105 1,262 4,419 3,814 370 413 5,310 4,839
200% or More 19,558 19,913 594a 438 18,963 19,476 2,828 3,105 16,135 16,370 1,216 1,264 18,342 18,649
HEALTH INSURANCE3                            
Private 17,906 18,460 501 398 17,405 18,062 3,193 3,660 14,212 14,402 1,325 1,286 16,581 17,174
Medicaid/CHIP 5,775 5,756 406 298 5,369 5,458 999 1,241 4,370 4,217 697 703 5,078 5,053
Other4 5,762 5,159 30 76 5,732 5,084 437 391 5,295 4,692 95a 168 5,667 4,992
No Coverage 3,416 3,229 59 42 3,356 3,188 740 630 2,617 2,557 201 168 3,214 3,061
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Alcohol use disorder (AUD) estimates are based on DSM-5 criteria.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 The Aged 12-20 and Aged 21+ columns are included because they are the underage and legal age groups for alcohol.
2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.12B – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic
Characteristic		 Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)		 Aged 12-201
(2021)		 Aged 12-201
(2022)		 Aged 21+1
(2021)		 Aged 21+1
(2022)
TOTAL 10.6 10.5 3.7a 2.9 11.3 11.2 15.5 16.4 10.7 10.4 5.7 5.7 11.4 11.2
GEOGRAPHIC REGION                    
Northeast 10.9 10.5 4.1 2.8 11.5 11.2 14.7 16.8 11.0 10.4 5.5 6.2 11.7 11.2
Midwest 10.6 11.0 3.9 2.5 11.3 11.9 15.2 16.8 10.7 11.1 6.2 5.9 11.3 11.8
South 10.0 9.3 3.2 3.0 10.7 9.9 15.0 14.2 10.1 9.3 5.3 5.2 10.8 10.0
West 11.5 11.9 4.1 3.3 12.3 12.7 17.0 19.2 11.5 11.7 6.2 6.0 12.4 12.8
COUNTY TYPE                            
Large Metro 10.9 10.7 3.6 2.7 11.6 11.6 15.5 16.2 11.0 10.8 5.8 5.2 11.7 11.6
Small Metro 10.9 10.7 4.0 3.2 11.6 11.4 15.9 16.6 10.8 10.6 6.1 6.3 11.6 11.4
Nonmetro 9.3 8.9 3.6 3.5 9.9 9.3 14.6 16.3 9.3 8.4 4.7 6.7 10.1 9.2
Urbanized 10.4 9.3 5.2 3.3 10.9 9.9 15.3 15.5 10.3 9.1 6.2 6.7 11.1 9.7
Less Urbanized 8.7 8.7 2.9 3.4 9.3 9.2 13.7 17.8 8.7 8.0 3.9 7.0 9.4 9.0
Completely Rural 8.8 7.4 1.1 * 9.5 7.7 16.9 * 8.6 7.4 3.3 * 9.6 7.7
POVERTY LEVEL2                            
Less Than 100% 10.4 10.5 3.9 2.7 11.3 11.7 14.7 16.4 10.3 10.4 6.9 6.3 11.3 11.7
100-199% 10.1 9.4 2.8 3.0 10.9 10.2 13.8 14.9 10.3 9.2 4.3 4.7 11.1 10.4
200% or More 10.9 10.8 4.0 3.0 11.5 11.4 16.8 17.0 10.9 10.8 5.8 6.0 11.5 11.4
HEALTH INSURANCE3                            
Private 10.6 10.9 3.6 2.8 11.3 11.6 16.9 18.4 10.5 10.6 6.4 6.2 11.2 11.5
Medicaid/CHIP 9.9 9.8 3.7 2.8 11.3 11.4 11.5 13.4 11.3 10.9 4.6 4.7 11.8 11.5
Other4 7.5 6.6 2.2 5.0 7.6 6.6 17.2 13.9 7.3 6.3 4.1 6.4 7.6 6.6
No Coverage 13.1 13.3 4.5 4.2 13.5 13.7 15.4 13.6 13.1 13.7 6.9 6.6 13.9 14.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Alcohol use disorder (AUD) estimates are based on DSM-5 criteria.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 The Aged 12-20 and Aged 21+ columns are included because they are the underage and legal age groups for alcohol.
2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.13A – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL 46,787 48,722 2,404 2,228 44,383 46,494 8,764b 9,669 35,619 36,825
GEOGRAPHIC REGION                    
Northeast 8,018 8,317 395 305 7,623 8,012 1,466 1,627 6,157 6,385
Midwest 10,367 10,503 599 463 9,768 10,039 1,926 2,113 7,841 7,926
South 16,640 17,046 753 895 15,887 16,151 3,119 3,357 12,768 12,793
West 11,762 12,857 656 565 11,106a 12,291 2,253 2,571 8,853 9,720
COUNTY TYPE                    
Large Metro 25,279 26,865 1,173 1,212 24,106 25,654 4,582a 5,258 19,524 20,396
Small Metro 14,441a 16,252 871 788 13,571a 15,465 2,962 3,376 10,609a 12,088
Nonmetro 7,067b 5,604 360a 229 6,707b 5,376 1,220 1,035 5,486a 4,341
Urbanized 2,687 2,457 169 108 2,518 2,349 535 476 1,983 1,873
Less Urbanized 3,642a 2,715 176 85 3,466a 2,630 581 521 2,885a 2,110
Completely Rural 738 432 15 * 722 397 105 * 617 358
POVERTY LEVEL1                    
Less Than 100% 8,387 8,661 525 412 7,862 8,249 2,118 2,139 5,744 6,110
100-199% 10,339 10,192 482 629 9,856 9,562 2,140a 2,526 7,717 7,036
200% or More 28,056 29,867 1,397 1,187 26,659 28,680 4,500 5,002 22,159 23,679
HEALTH INSURANCE2                    
Private 25,100a 27,364 1,212 1,095 23,888a 26,269 4,951a 5,814 18,937 20,455
Medicaid/CHIP 12,104 12,773 1,101 1,044 11,003 11,729 2,120 2,438 8,883 9,291
Other3 9,564 9,325 75a 154 9,489 9,172 752 748 8,737 8,423
No Coverage 5,736 5,163 140 84 5,596 5,079 1,295 1,124 4,301 3,955
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.13B – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL 16.7 17.3 9.2 8.7 17.5 18.1 26.2 27.8 16.2 16.6
GEOGRAPHIC REGION                    
Northeast 16.4 17.0 9.5 7.5 17.0 17.8 25.6 27.5 15.8 16.4
Midwest 17.9 18.1 10.9 8.6 18.6 19.0 27.1 29.0 17.3 17.4
South 15.6 15.8 7.4 8.8 16.5 16.5 24.6 25.2 15.2 15.1
West 17.7 19.3 10.5 9.2 18.5 20.3 28.4 31.2 17.0 18.6
COUNTY TYPE                    
Large Metro 16.8 17.2 8.4 8.2 17.6 18.2 26.0 27.5 16.4 16.7
Small Metro 16.8a 18.2 10.9 9.9 17.4a 19.0 27.0 28.9 15.9 17.4
Nonmetro 16.3 15.3 9.0 7.8 17.1 15.9 25.2 26.0 15.9 14.6
Urbanized 16.6 15.9 11.1 8.8 17.2 16.5 26.4 27.0 15.7 15.0
Less Urbanized 16.1 14.7 8.5 6.0 16.9 15.5 24.7 26.4 15.9 14.0
Completely Rural 16.2 15.1 3.9 * 17.4 15.4 22.5 * 16.7 15.4
POVERTY LEVEL1                    
Less Than 100% 19.3 20.9 9.6 7.8 20.8 22.8 25.0 26.6 19.5 21.7
100-199% 18.3 18.3 8.6 10.9 19.4 19.2 26.7 29.8 18.0 17.0
200% or More 15.6 16.2 9.4 8.1 16.1 16.8 26.7 27.4 15.0 15.6
HEALTH INSURANCE2                    
Private 14.9a 16.1 8.7 7.8 15.5a 16.8 26.2a 29.3 14.0 15.0
Medicaid/CHIP 20.8 21.7 10.1 9.8 23.2 24.4 24.4 26.3 22.9 23.9
Other3 12.5 11.9 5.4a 10.2 12.6 12.0 29.6 26.7 12.0 11.4
No Coverage 22.0 21.3 10.6 8.4 22.6 21.9 27.0 24.3 21.5 21.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.14A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2021 and 2022
Age Category Treatment for
Drugs
(2021)		 Treatment for
Drugs
(2022)		 Treatment for
Alcohol
(2021)		 Treatment for
Alcohol
(2022)		 Treatment for
Both Drugs
and Alcohol
(2021)		 Treatment for
Both Drugs
and Alcohol
(2022)		 Treatment for
Substance
Unspecified1
(2021)		 Treatment for
Substance
Unspecified1
(2022)		 Treatment for
Drugs or
Alcohol1
(2021)		 Treatment for
Drugs or
Alcohol1
(2022)
TOTAL -- 6,185 -- 4,338 -- 1,669 -- 4,251 -- 13,106
12-202 -- 986 -- 333 -- 134 -- 559 -- 1,744
21 or Older2 -- 5,199 -- 4,005 -- 1,534 -- 3,693 -- 11,362
12-17 -- 721 -- 214 -- 70 -- 320 -- 1,184
12-13 -- 196 -- 50 -- 13 -- 75 -- 307
14-15 -- 258 -- 71 -- 13 -- 154 -- 469
16-17 -- 267 -- 94 -- 44 -- 91 -- 408
18 or Older -- 5,464 -- 4,124 -- 1,598 -- 3,932 -- 11,922
18-25 -- 775 -- 495 -- 212 -- 616 -- 1,673
18-20 -- 265 -- 119 -- 64 -- 239 -- 559
21-25 -- 510 -- 375 -- 148 -- 377 -- 1,114
26 or Older -- 4,689 -- 3,630 -- 1,386 -- 3,316 -- 10,248
26-49 -- 2,978 -- 1,983 -- 863 -- 1,630 -- 5,728
26-29 -- 397 -- 331 -- 150 -- 197 -- 776
30-34 -- 731 -- 476 -- 263 -- 467 -- 1,411
35-39 -- 773 -- 424 -- 160 -- 247 -- 1,284
40-44 -- 573 -- 390 -- 118 -- 369 -- 1,215
45-49 -- 503 -- 362 -- 172 -- 349 -- 1,042
50 or Older -- 1,711 -- 1,647 -- 523 -- 1,686 -- 4,521
50-54 -- 423 -- 491 -- 212 -- 313 -- 1,015
55-59 -- 312 -- 336 -- 132 -- 392 -- 908
60-64 -- 628 -- 285 -- 127 -- 411 -- 1,197
65 or Older -- 348 -- 536 -- 52 -- 569 -- 1,401
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
1 These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
2 The 12-20 and 21 or Older rows are included because they are the underage and legal age groups for alcohol.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.14B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2021 and 2022
Age Category Treatment for
Drugs
(2021)		 Treatment for
Drugs
(2022)		 Treatment for
Alcohol
(2021)		 Treatment for
Alcohol
(2022)		 Treatment for
Both Drugs
and Alcohol
(2021)		 Treatment for
Both Drugs
and Alcohol
(2022)		 Treatment for
Substance
Unspecified1
(2021)		 Treatment for
Substance
Unspecified1
(2022)		 Treatment for
Drugs or
Alcohol1
(2021)		 Treatment for
Drugs or
Alcohol1
(2022)
TOTAL -- 2.2 -- 1.5 -- 0.6 -- 1.5 -- 4.6
12-202 -- 2.6 -- 0.9 -- 0.3 -- 1.4 -- 4.5
21 or Older2 -- 2.1 -- 1.6 -- 0.6 -- 1.5 -- 4.7
12-17 -- 2.8 -- 0.8 -- 0.3 -- 1.2 -- 4.6
12-13 -- 2.3 -- 0.6 -- 0.2 -- 0.9 -- 3.6
14-15 -- 2.8 -- 0.8 -- 0.1 -- 1.7 -- 5.2
16-17 -- 3.2 -- 1.1 -- 0.5 -- 1.1 -- 5.0
18 or Older -- 2.1 -- 1.6 -- 0.6 -- 1.5 -- 4.7
18-25 -- 2.2 -- 1.4 -- 0.6 -- 1.8 -- 4.8
18-20 -- 2.1 -- 0.9 -- 0.5 -- 1.8 -- 4.3
21-25 -- 2.3 -- 1.7 -- 0.7 -- 1.7 -- 5.1
26 or Older -- 2.1 -- 1.6 -- 0.6 -- 1.5 -- 4.6
26-49 -- 2.9 -- 1.9 -- 0.8 -- 1.6 -- 5.6
26-29 -- 2.3 -- 1.9 -- 0.9 -- 1.2 -- 4.6
30-34 -- 3.2 -- 2.1 -- 1.1 -- 2.0 -- 6.1
35-39 -- 3.5 -- 1.9 -- 0.7 -- 1.1 -- 5.8
40-44 -- 2.8 -- 1.9 -- 0.6 -- 1.8 -- 5.8
45-49 -- 2.6 -- 1.9 -- 0.9 -- 1.8 -- 5.3
50 or Older -- 1.4 -- 1.4 -- 0.4 -- 1.4 -- 3.8
50-54 -- 2.1 -- 2.5 -- 1.1 -- 1.6 -- 5.1
55-59 -- 1.6 -- 1.7 -- 0.7 -- 2.0 -- 4.5
60-64 -- 2.8 -- 1.3 -- 0.6 -- 1.8 -- 5.3
65 or Older -- 0.6 -- 0.9 -- 0.1 -- 1.0 -- 2.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
1 These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
2 The 12-20 and 21 or Older rows are included because they are the underage and legal age groups for alcohol.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.15A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL -- 13,106 -- 1,184 -- 11,922 -- 1,673 -- 10,248
GENDER                    
Male -- 7,261 -- 452 -- 6,809 -- 741 -- 6,068
Female -- 5,845 -- 732 -- 5,113 -- 932 -- 4,181
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino -- 10,992 -- 845 -- 10,146 -- 1,334 -- 8,812
AIAN -- 126 -- 14 -- 112 -- 14 -- 98
Asian -- 387 -- 38 -- 348 -- 30 -- 318
Black or African American -- 1,582 -- 208 -- 1,375 -- 203 -- 1,172
NHOPI -- * -- * -- * -- * -- *
White -- 8,416 -- 543 -- 7,874 -- 1,050 -- 6,824
Two or More Races -- 348 -- 42 -- 307 -- 38 -- 269
Hispanic or Latino -- 2,114 -- 339 -- 1,775 -- 339 -- 1,436
EDUCATION LEVEL                    
< High School da da da da -- 1,592 -- 273 -- 1,320
High School Graduate da da da da -- 4,128 -- 595 -- 3,533
Some College/Associate’s Degree da da da da -- 4,361 -- 686 -- 3,675
College Graduate da da da da -- 1,841 -- 120 -- 1,720
EMPLOYMENT STATUS                    
Full-Time da da da da -- 4,220 -- 595 -- 3,624
Part-Time da da da da -- 1,748 -- 415 -- 1,332
Unemployed da da da da -- 935 -- 174 -- 760
Other1 da da da da -- 5,020 -- 488 -- 4,532
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.15B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL -- 4.6 -- 4.6 -- 4.7 -- 4.8 -- 4.6
GENDER                    
Male -- 5.3 -- 3.4 -- 5.4 -- 4.2 -- 5.6
Female -- 4.1 -- 5.8 -- 3.9 -- 5.4 -- 3.7
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino -- 4.8 -- 4.4 -- 4.8 -- 5.0 -- 4.8
AIAN -- 8.6 -- 6.5 -- 9.0 -- 6.4 -- 9.5
Asian -- 2.3 -- 2.4 -- 2.3 -- 1.3 -- 2.4
Black or African American -- 4.6 -- 5.9 -- 4.4 -- 4.3 -- 4.5
NHOPI -- * -- * -- * -- * -- *
White -- 4.9 -- 4.2 -- 5.0 -- 5.8 -- 4.9
Two or More Races -- 5.9 -- 5.0 -- 6.1 -- 3.8 -- 6.6
Hispanic or Latino -- 4.2 -- 5.1 -- 4.0 -- 4.1 -- 4.0
EDUCATION LEVEL                    
< High School da da da da -- 6.5 -- 7.6 -- 6.4
High School Graduate da da da da -- 6.0 -- 5.1 -- 6.1
Some College/Associate’s Degree da da da da -- 5.6 -- 4.9 -- 5.8
College Graduate da da da da -- 2.2 -- 2.1 -- 2.2
EMPLOYMENT STATUS                    
Full-Time da da da da -- 3.6 -- 4.2 -- 3.5
Part-Time da da da da -- 5.3 -- 4.7 -- 5.5
Unemployed da da da da -- 8.5 -- 5.4 -- 9.7
Other1 da da da da -- 5.3 -- 5.6 -- 5.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.16A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Treatment for
Drugs
(2021)		 Treatment for
Drugs
(2022)		 Treatment for
Alcohol
(2021)		 Treatment for
Alcohol
(2022)		 Treatment for
Both Drugs
and Alcohol
(2021)		 Treatment for
Both Drugs
and Alcohol
(2022)		 Treatment for
Substance
Unspecified1
(2021)		 Treatment for
Substance
Unspecified1
(2022)		 Treatment for
Drugs or
Alcohol1
(2021)		 Treatment for
Drugs or
Alcohol1
(2022)
TOTAL -- 6,185 -- 4,338 -- 1,669 -- 4,251 -- 13,106
GENDER                    
Male -- 3,375 -- 2,674 -- 1,024 -- 2,236 -- 7,261
Female -- 2,810 -- 1,664 -- 645 -- 2,016 -- 5,845
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino -- 5,050 -- 3,534 -- 1,353 -- 3,761 -- 10,992
AIAN -- 94 -- 64 -- 38 -- 6 -- 126
Asian -- 63 -- 133 -- 24 -- 215 -- 387
Black or African American -- 745 -- 507 -- 232 -- 562 -- 1,582
NHOPI -- * -- * -- * -- * -- *
White -- 3,965 -- 2,735 -- 1,011 -- 2,727 -- 8,416
Two or More Races -- 151 -- 60 -- 17 -- 155 -- 348
Hispanic or Latino -- 1,135 -- 804 -- 316 -- 491 -- 2,114
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
1 These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.16B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Treatment for
Drugs
(2021)		 Treatment for
Drugs
(2022)		 Treatment for
Alcohol
(2021)		 Treatment for
Alcohol
(2022)		 Treatment for
Both Drugs
and Alcohol
(2021)		 Treatment for
Both Drugs
and Alcohol
(2022)		 Treatment for
Substance
Unspecified1
(2021)		 Treatment for
Substance
Unspecified1
(2022)		 Treatment for
Drugs or
Alcohol1
(2021)		 Treatment for
Drugs or
Alcohol1
(2022)
TOTAL -- 2.2 -- 1.5 -- 0.6 -- 1.5 -- 4.6
GENDER                    
Male -- 2.4 -- 1.9 -- 0.7 -- 1.6 -- 5.3
Female -- 2.0 -- 1.2 -- 0.4 -- 1.4 -- 4.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino -- 2.2 -- 1.5 -- 0.6 -- 1.6 -- 4.8
AIAN -- 6.4 -- 4.4 -- 2.6 -- 0.4 -- 8.6
Asian -- 0.4 -- 0.8 -- 0.1 -- 1.3 -- 2.3
Black or African American -- 2.2 -- 1.5 -- 0.7 -- 1.6 -- 4.6
NHOPI -- * -- * -- * -- * -- *
White -- 2.3 -- 1.6 -- 0.6 -- 1.6 -- 4.9
Two or More Races -- 2.6 -- 1.0 -- 0.3 -- 2.6 -- 5.9
Hispanic or Latino -- 2.2 -- 1.6 -- 0.6 -- 1.0 -- 4.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
1 These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.17A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older with Past Year Substance Use Disorder; by Age Group and Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL -- 7,253 -- 453 -- 6,800 -- 1,164 -- 5,636
GENDER                    
Male -- 4,046 -- 153 -- 3,893 -- 508 -- 3,385
Female -- 3,207 -- 300 -- 2,906 -- 656 -- 2,250
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino -- 6,144 -- 335 -- 5,809 -- 927 -- 4,882
AIAN -- * -- * -- * -- * -- *
Asian -- * -- * -- * -- 12 -- *
Black or African American -- 883 -- 55 -- 828 -- 132 -- 696
NHOPI -- * -- * -- * -- * -- *
White -- 4,689 -- 234 -- 4,455 -- 749 -- 3,706
Two or More Races -- 213 -- * -- 191 -- 24 -- 168
Hispanic or Latino -- 1,108 -- 118 -- 991 -- 237 -- 754
EDUCATION LEVEL                    
< High School da da da da -- 908 -- 173 -- 736
High School Graduate da da da da -- 2,309 -- 380 -- 1,929
Some College/Associate’s Degree da da da da -- 2,594 -- 513 -- 2,080
College Graduate da da da da -- 989 -- 98 -- 891
EMPLOYMENT STATUS                    
Full-Time da da da da -- 2,516 -- 440 -- 2,076
Part-Time da da da da -- 1,069 -- 316 -- 753
Unemployed da da da da -- 607 -- 140 -- 467
Other1 da da da da -- 2,607 -- 267 -- 2,340
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.17B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older with Past Year Substance Use Disorder; by Age Group and Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
TOTAL -- 14.9 -- 20.3 -- 14.6 -- 12.0 -- 15.3
GENDER                    
Male -- 14.6 -- 15.6 -- 14.6 -- 10.1 -- 15.7
Female -- 15.2 -- 24.0 -- 14.7 -- 14.2 -- 14.8
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino -- 15.4 -- 21.5 -- 15.2 -- 12.5 -- 15.8
AIAN -- * -- * -- * -- * -- *
Asian -- * -- * -- * -- 4.1 -- *
Black or African American -- 14.0 -- 17.6 -- 13.8 -- 11.9 -- 14.2
NHOPI -- * -- * -- * -- * -- *
White -- 15.6 -- 21.7 -- 15.4 -- 13.4 -- 15.8
Two or More Races -- 16.7 -- * -- 16.0 -- 7.8 -- 18.7
Hispanic or Latino -- 12.5 -- 17.6 -- 12.1 -- 10.5 -- 12.7
EDUCATION LEVEL                    
< High School da da da da -- 21.0 -- 18.1 -- 21.8
High School Graduate da da da da -- 18.3 -- 12.4 -- 20.1
Some College/Associate’s Degree da da da da -- 16.3 -- 13.0 -- 17.5
College Graduate da da da da -- 7.2 -- 5.8 -- 7.4
EMPLOYMENT STATUS                    
Full-Time da da da da -- 10.6 -- 9.8 -- 10.7
Part-Time da da da da -- 15.9 -- 13.1 -- 17.4
Unemployed da da da da -- 19.8 -- 15.4 -- 21.6
Other1 da da da da -- 20.3 -- 14.3 -- 21.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.18A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic Treatment
for Drugs
(2021)		 Treatment
for Drugs
(2022)		 Treatment
for Alcohol
(2021)		 Treatment
for Alcohol
(2022)		 Treatment
for Both
Drugs and
Alcohol
(2021)		 Treatment
for Both
Drugs and
Alcohol
(2022)		 Treatment for
Substance
Unspecified1
(2021)		 Treatment for
Substance
Unspecified1
(2022)		 Treatment
for Drugs
or Alcohol1
(2021)		 Treatment
for Drugs
or Alcohol1
(2022)
TOTAL -- 6,185 -- 4,338 -- 1,669 -- 4,251 -- 13,106
GEOGRAPHIC REGION                    
Northeast -- 1,145 -- 940 -- 312 -- 867 -- 2,640
Midwest -- 1,351 -- 912 -- 322 -- 1,016 -- 2,957
South -- 2,255 -- 1,481 -- 602 -- 1,521 -- 4,655
West -- 1,434 -- 1,005 -- 433 -- 848 -- 2,853
COUNTY TYPE                    
Large Metro -- 3,022 -- 2,187 -- 828 -- 1,966 -- 6,347
Small Metro -- 2,190 -- 1,449 -- 609 -- 1,555 -- 4,585
Nonmetro -- 973 -- 702 -- 231 -- 730 -- 2,173
Urbanized -- 373 -- 223 -- 47 -- 356 -- 904
Less Urbanized -- 506 -- 457 -- 172 -- 264 -- 1,055
Completely Rural -- 93 -- 22 -- 11 -- 110 -- 214
POVERTY LEVEL2                    
Less Than 100% -- 1,844 -- 1,075 -- 464 -- 1,155 -- 3,610
100-199% -- 1,881 -- 1,174 -- 560 -- 1,097 -- 3,591
200% or More -- 2,460 -- 2,090 -- 644 -- 1,999 -- 5,905
HEALTH INSURANCE3                    
Private -- 2,223 -- 1,849 -- 643 -- 1,907 -- 5,337
Medicaid/CHIP -- 3,225 -- 1,655 -- 877 -- 1,636 -- 5,639
Other4 -- 1,509 -- 1,349 -- 441 -- 1,540 -- 3,957
No Coverage -- 500 -- 523 -- 177 -- 256 -- 1,102
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
1 These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.18B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic Treatment
for Drugs
(2021)		 Treatment
for Drugs
(2022)		 Treatment
for Alcohol
(2021)		 Treatment
for Alcohol
(2022)		 Treatment
for Both
Drugs and
Alcohol
(2021)		 Treatment
for Both
Drugs and
Alcohol
(2022)		 Treatment for
Substance
Unspecified1
(2021)		 Treatment for
Substance
Unspecified1
(2022)		 Treatment
for Drugs
or Alcohol1
(2021)		 Treatment
for Drugs
or Alcohol1
(2022)
TOTAL -- 2.2 -- 1.5 -- 0.6 -- 1.5 -- 4.6
GEOGRAPHIC REGION                    
Northeast -- 2.3 -- 1.9 -- 0.6 -- 1.8 -- 5.4
Midwest -- 2.3 -- 1.6 -- 0.6 -- 1.7 -- 5.1
South -- 2.1 -- 1.4 -- 0.6 -- 1.4 -- 4.3
West -- 2.1 -- 1.5 -- 0.6 -- 1.3 -- 4.3
COUNTY TYPE                    
Large Metro -- 1.9 -- 1.4 -- 0.5 -- 1.3 -- 4.1
Small Metro -- 2.5 -- 1.6 -- 0.7 -- 1.7 -- 5.1
Nonmetro -- 2.6 -- 1.9 -- 0.6 -- 2.0 -- 5.9
Urbanized -- 2.4 -- 1.4 -- 0.3 -- 2.3 -- 5.8
Less Urbanized -- 2.7 -- 2.5 -- 0.9 -- 1.4 -- 5.7
Completely Rural -- 3.3 -- 0.8 -- 0.4 -- 3.8 -- 7.5
POVERTY LEVEL2                    
Less Than 100% -- 4.4 -- 2.6 -- 1.1 -- 2.8 -- 8.7
100-199% -- 3.4 -- 2.1 -- 1.0 -- 2.0 -- 6.5
200% or More -- 1.3 -- 1.1 -- 0.3 -- 1.1 -- 3.2
HEALTH INSURANCE3                    
Private -- 1.3 -- 1.1 -- 0.4 -- 1.1 -- 3.1
Medicaid/CHIP -- 5.5 -- 2.8 -- 1.5 -- 2.8 -- 9.6
Other4 -- 1.9 -- 1.7 -- 0.6 -- 2.0 -- 5.1
No Coverage -- 2.1 -- 2.2 -- 0.7 -- 1.1 -- 4.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
1 These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.19A – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Inpatient in Past Year; Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Outpatient in Past Year; Numbers in Thousands, 2021 and 2022
Substance for Which Treatment Was Received1 Inpatient
(2021)		 Inpatient
(2022)		 Outpatient
(2021)		 Outpatient
(2022)
DRUGS OR ALCOHOL2 -- 3,488 -- 9,910
DRUGS -- 1,507 -- 3,806
Marijuana -- 429 -- 905
Cocaine -- 309 -- 535
Heroin -- 341 -- 789
Hallucinogens -- 105 -- 156
Inhalants -- 83 -- 98
Methamphetamine -- 476 -- 708
Prescription Psychotherapeutics -- 638 -- 2,158
Pain Relievers -- 467 -- 1,571
Stimulants -- 194 -- 476
Tranquilizers or Sedatives -- 205 -- 540
Tranquilizers -- 150 -- 455
Sedatives -- 120 -- 236
Opioids -- 712 -- 2,058
Central Nervous System Stimulants -- 810 -- 1,467
ALCOHOL -- 1,267 -- 2,520
BOTH DRUGS AND ALCOHOL -- 367 -- 736
SUBSTANCE UNSPECIFIED2 -- 1,083 -- 4,320
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
1 Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive.
2 These estimates include data from respondents who reported that they received inpatient or outpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.19B – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Inpatient in Past Year; Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Outpatient in Past Year; Percentages, 2021 and 2022
Substance for Which Treatment Was Received1 Inpatient
(2021)		 Inpatient
(2022)		 Outpatient
(2021)		 Outpatient
(2022)
DRUGS OR ALCOHOL2 -- 100.0 -- 100.0
DRUGS -- 43.2 -- 38.4
Marijuana -- 12.3 -- 9.1
Cocaine -- 8.9 -- 5.4
Heroin -- 9.8 -- 8.0
Hallucinogens -- 3.0 -- 1.6
Inhalants -- 2.4 -- 1.0
Methamphetamine -- 13.7 -- 7.1
Prescription Psychotherapeutics -- 18.3 -- 21.8
Pain Relievers -- 13.4 -- 15.9
Stimulants -- 5.6 -- 4.8
Tranquilizers or Sedatives -- 5.9 -- 5.5
Tranquilizers -- 4.3 -- 4.6
Sedatives -- 3.4 -- 2.4
Opioids -- 20.4 -- 20.8
Central Nervous System Stimulants -- 23.2 -- 14.8
ALCOHOL -- 36.3 -- 25.4
BOTH DRUGS AND ALCOHOL -- 10.5 -- 7.4
SUBSTANCE UNSPECIFIED2 -- 31.0 -- 43.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
1 Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive.
2 These estimates include data from respondents who reported that they received inpatient or outpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.20A – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Inpatient in Past Year; by Age Group, Numbers in Thousands, 2021 and 2022
Substance for Which Treatment
Was Received1		 Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
DRUGS OR ALCOHOL2 -- 3,488 -- 331 -- 3,158 -- 494 -- 2,664
DRUGS -- 1,507 -- 192 -- 1,314 -- 226 -- 1,089
Marijuana -- 429 -- 75 -- 354 -- 98 -- 256
Cocaine -- 309 -- 2 -- 308 -- 26 -- 282
Heroin -- 341 -- 0 -- 340 -- 22 -- 319
Hallucinogens -- 105 -- 30 -- 75 -- 35 -- 40
Inhalants -- 83 -- 17 -- 66 -- 15 -- 51
Methamphetamine -- 476 -- 3 -- 474 -- 55 -- 419
Prescription Psychotherapeutics -- 638 -- 123 -- 516 -- 117 -- 399
Pain Relievers -- 467 -- 73 -- 394 -- 75 -- 318
Stimulants -- 194 -- 39 -- 155 -- * -- 112
Tranquilizers or Sedatives -- 205 -- 37 -- 168 -- 21 -- 147
Tranquilizers -- 150 -- 13 -- 137 -- 17 -- 119
Sedatives -- 120 -- * -- 94 -- 11 -- 83
Opioids -- 712 -- 73 -- 639 -- 87 -- 552
Central Nervous System Stimulants -- 810 -- 42 -- 769 -- 91 -- 678
ALCOHOL -- 1,267 -- 59 -- 1,208 -- 167 -- 1,041
BOTH DRUGS AND ALCOHOL -- 367 -- 17 -- 350 -- 67 -- 283
SUBSTANCE UNSPECIFIED2 -- 1,083 -- 97 -- 985 -- 169 -- 816
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
1 Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive.
2 These estimates include data from respondents who reported that they received inpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.20B – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Inpatient in Past Year; by Age Group, Percentages, 2021 and 2022
Substance for Which Treatment
Was Received1		 Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
DRUGS OR ALCOHOL2 -- 100.0 -- 100.0 -- 100.0 -- 100.0 -- 100.0
DRUGS -- 43.2 -- 58.1 -- 41.6 -- 45.7 -- 40.9
Marijuana -- 12.3 -- 22.7 -- 11.2 -- 19.7 -- 9.6
Cocaine -- 8.9 -- 0.5 -- 9.7 -- 5.2 -- 10.6
Heroin -- 9.8 -- 0.1 -- 10.8 -- 4.4 -- 12.0
Hallucinogens -- 3.0 -- 9.2 -- 2.4 -- 7.1 -- 1.5
Inhalants -- 2.4 -- 5.2 -- 2.1 -- 3.0 -- 1.9
Methamphetamine -- 13.7 -- 0.8 -- 15.0 -- 11.1 -- 15.7
Prescription Psychotherapeutics -- 18.3 -- 37.1 -- 16.3 -- 23.7 -- 15.0
Pain Relievers -- 13.4 -- 22.1 -- 12.5 -- 15.2 -- 12.0
Stimulants -- 5.6 -- 11.8 -- 4.9 -- * -- 4.2
Tranquilizers or Sedatives -- 5.9 -- 11.3 -- 5.3 -- 4.3 -- 5.5
Tranquilizers -- 4.3 -- 4.0 -- 4.3 -- 3.5 -- 4.5
Sedatives -- 3.4 -- * -- 3.0 -- 2.2 -- 3.1
Opioids -- 20.4 -- 22.1 -- 20.2 -- 17.5 -- 20.7
Central Nervous System Stimulants -- 23.2 -- 12.6 -- 24.3 -- 18.4 -- 25.4
ALCOHOL -- 36.3 -- 17.7 -- 38.3 -- 33.8 -- 39.1
BOTH DRUGS AND ALCOHOL -- 10.5 -- 5.2 -- 11.1 -- 13.6 -- 10.6
SUBSTANCE UNSPECIFIED2 -- 31.0 -- 29.4 -- 31.2 -- 34.2 -- 30.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
1 Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive.
2 These estimates include data from respondents who reported that they received inpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.21A – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Outpatient in Past Year; by Age Group, Numbers in Thousands, 2021 and 2022
Substance for Which Treatment
Was Received1		 Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
DRUGS OR ALCOHOL2 -- 9,910 -- 952 -- 8,958 -- 1,203 -- 7,755
DRUGS -- 3,806 -- 523 -- 3,283 -- 474 -- 2,809
Marijuana -- 905 -- 199 -- 705 -- 231 -- 474
Cocaine -- 535 -- 4 -- 531 -- 44 -- 488
Heroin -- 789 -- 0 -- 789 -- 36 -- 752
Hallucinogens -- 156 -- 35 -- 121 -- 29 -- 92
Inhalants -- 98 -- 54 -- 44 -- 33 -- 11
Methamphetamine -- 708 -- 6 -- 702 -- 54 -- 648
Prescription Psychotherapeutics -- 2,158 -- 337 -- 1,821 -- 217 -- 1,604
Pain Relievers -- 1,571 -- 225 -- 1,346 -- 102 -- 1,244
Stimulants -- 476 -- 103 -- 373 -- 104 -- 269
Tranquilizers or Sedatives -- 540 -- 55 -- 486 -- 51 -- 434
Tranquilizers -- 455 -- 32 -- 423 -- 39 -- 384
Sedatives -- 236 -- 32 -- 204 -- 29 -- 175
Opioids -- 2,058 -- 225 -- 1,833 -- 115 -- 1,717
Central Nervous System Stimulants -- 1,467 -- 112 -- 1,354 -- 163 -- 1,191
ALCOHOL -- 2,520 -- 136 -- 2,384 -- 247 -- 2,136
BOTH DRUGS AND ALCOHOL -- 736 -- 38 -- 698 -- 98 -- 600
SUBSTANCE UNSPECIFIED2 -- 4,320 -- 331 -- 3,989 -- 580 -- 3,409
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
1 Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive.
2 These estimates include data from respondents who reported that they received outpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.21B – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Outpatient in Past Year; by Age Group, Percentages, 2021 and 2022
Substance for Which Treatment
Was Received1		 Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
DRUGS OR ALCOHOL2 -- 100.0 -- 100.0 -- 100.0 -- 100.0 -- 100.0
DRUGS -- 38.4 -- 54.9 -- 36.7 -- 39.4 -- 36.2
Marijuana -- 9.1 -- 20.9 -- 7.9 -- 19.2 -- 6.1
Cocaine -- 5.4 -- 0.4 -- 5.9 -- 3.6 -- 6.3
Heroin -- 8.0 -- 0.0 -- 8.8 -- 3.0 -- 9.7
Hallucinogens -- 1.6 -- 3.7 -- 1.4 -- 2.4 -- 1.2
Inhalants -- 1.0 -- 5.7 -- 0.5 -- 2.7 -- 0.1
Methamphetamine -- 7.1 -- 0.6 -- 7.8 -- 4.5 -- 8.4
Prescription Psychotherapeutics -- 21.8 -- 35.4 -- 20.3 -- 18.0 -- 20.7
Pain Relievers -- 15.9 -- 23.6 -- 15.0 -- 8.4 -- 16.0
Stimulants -- 4.8 -- 10.8 -- 4.2 -- 8.7 -- 3.5
Tranquilizers or Sedatives -- 5.5 -- 5.7 -- 5.4 -- 4.3 -- 5.6
Tranquilizers -- 4.6 -- 3.3 -- 4.7 -- 3.2 -- 5.0
Sedatives -- 2.4 -- 3.4 -- 2.3 -- 2.4 -- 2.3
Opioids -- 20.8 -- 23.6 -- 20.5 -- 9.6 -- 22.1
Central Nervous System Stimulants -- 14.8 -- 11.8 -- 15.1 -- 13.6 -- 15.4
ALCOHOL -- 25.4 -- 14.3 -- 26.6 -- 20.6 -- 27.6
BOTH DRUGS AND ALCOHOL -- 7.4 -- 4.0 -- 7.8 -- 8.1 -- 7.7
SUBSTANCE UNSPECIFIED2 -- 43.6 -- 34.8 -- 44.5 -- 48.2 -- 44.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
1 Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive.
2 These estimates include data from respondents who reported that they received outpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.22A – Received Medication-Assisted Treatment (MAT) for Alcohol Use in Past Year: Among People Aged 12 or Older; Received MAT for Alcohol Use in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Received MAT for
Alcohol Use
(2021)		 Received MAT for
Alcohol Use
(2022)		 Received MAT for
Alcohol Use among
People with an Alcohol
Use Disorder1
(2021)		 Received MAT for
Alcohol Use among
People with an Alcohol
Use Disorder1
(2022)
TOTAL -- 1,243 -- 634
AGE GROUP        
12-17 -- 44 -- 10
18 or Older -- 1,199 -- 624
18-25 -- 95 -- 26
26 or Older -- 1,104 -- 598
GENDER        
Male -- 889 -- 500
Female -- 354 -- 134
HISPANIC ORIGIN AND RACE        
Not Hispanic or Latino -- 1,035 -- 547
AIAN -- 17 -- 5
Asian -- 27 -- *
Black or African American -- 151 -- 95
NHOPI -- * -- *
White -- 802 -- 416
Two or More Races -- 12 -- 6
Hispanic or Latino -- 208 -- 86
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Medication-assisted treatment for alcohol use refers to medication prescribed by a doctor or other health professional to help reduce or stop the use of alcohol.
1 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.22B – Received Medication-Assisted Treatment (MAT) for Alcohol Use in Past Year: Among People Aged 12 or Older; Received MAT for Alcohol Use in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Received MAT for
Alcohol Use
(2021)		 Received MAT for
Alcohol Use
(2022)		 Received MAT for
Alcohol Use among
People with an Alcohol
Use Disorder1
(2021)		 Received MAT for
Alcohol Use among
People with an Alcohol
Use Disorder1
(2022)
TOTAL -- 0.4 -- 2.1
AGE GROUP        
12-17 -- 0.2 -- 1.3
18 or Older -- 0.5 -- 2.2
18-25 -- 0.3 -- 0.4
26 or Older -- 0.5 -- 2.6
GENDER        
Male -- 0.6 -- 2.9
Female -- 0.2 -- 1.1
HISPANIC ORIGIN AND RACE        
Not Hispanic or Latino -- 0.4 -- 2.3
AIAN -- 1.1 -- 2.9
Asian -- 0.2 -- *
Black or African American -- 0.4 -- 2.6
NHOPI -- * -- *
White -- 0.5 -- 2.2
Two or More Races -- 0.2 -- 0.9
Hispanic or Latino -- 0.4 -- 1.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Medication-assisted treatment for alcohol use refers to medication prescribed by a doctor or other health professional to help reduce or stop the use of alcohol.
1 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.23A – Received Medication-Assisted Treatment (MAT) for Opioid Use in Past Year: Among People Aged 12 or Older; Received MAT for Opioid Use in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Received MAT for
Opioid Use
(2021)		 Received MAT for
Opioid Use
(2022)		 Received MAT for
Opioid Use among
People with an Opioid
Use Disorder1
(2021)		 Received MAT for
Opioid Use among
People with an Opioid
Use Disorder1
(2022)
TOTAL -- 2,392 -- 1,121
AGE GROUP        
12-17 -- 40 -- 20
18 or Older -- 2,353 -- 1,102
18-25 -- 90 -- 44
26 or Older -- 2,262 -- 1,058
GENDER        
Male -- 1,395 -- 698
Female -- 997 -- 424
HISPANIC ORIGIN AND RACE        
Not Hispanic or Latino -- 2,067 -- 951
AIAN -- 17 -- *
Asian -- 6 -- *
Black or African American -- 213 -- 117
NHOPI -- * -- *
White -- 1,748 -- 758
Two or More Races -- 57 -- *
Hispanic or Latino -- 325 -- 171
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Medication-assisted treatment for opioid use refers to medication prescribed by a doctor or other health professional to help reduce or stop the use of opioids.
1 Opioid use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include opioid use disorder data from all past year users of opioids. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.23B – Received Medication-Assisted Treatment (MAT) for Opioid Use in Past Year: Among People Aged 12 or Older; Received MAT for Opioid Use in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Received MAT for
Opioid Use
(2021)		 Received MAT for
Opioid Use
(2022)		 Received MAT for
Opioid Use among
People with an Opioid
Use Disorder1
(2021)		 Received MAT for
Opioid Use among
People with an Opioid
Use Disorder1
(2022)
TOTAL -- 0.8 -- 18.3
AGE GROUP        
12-17 -- 0.2 -- 7.5
18 or Older -- 0.9 -- 18.8
18-25 -- 0.3 -- 10.3
26 or Older -- 1.0 -- 19.5
GENDER        
Male -- 1.0 -- 22.9
Female -- 0.7 -- 13.8
HISPANIC ORIGIN AND RACE        
Not Hispanic or Latino -- 0.9 -- 18.7
AIAN -- 1.2 -- *
Asian -- 0.0 -- *
Black or African American -- 0.6 -- 11.2
NHOPI -- * -- *
White -- 1.0 -- 21.7
Two or More Races -- 1.0 -- *
Hispanic or Latino -- 0.6 -- 16.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Medication-assisted treatment for opioid use refers to medication prescribed by a doctor or other health professional to help reduce or stop the use of opioids.
1 Opioid use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include opioid use disorder data from all past year users of opioids. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.24A – Received Medication-Assisted Treatment (MAT) for Alcohol Use in Past Year: Among People Aged 12 or Older; Received MAT for Alcohol Use in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic Received MAT for
Alcohol Use
(2021)		 Received MAT for
Alcohol Use
(2022)		 Received MAT for
Alcohol Use among
People with an Alcohol
Use Disorder1
(2021)		 Received MAT for
Alcohol Use among
People with an Alcohol
Use Disorder1
(2022)
TOTAL -- 1,243 -- 634
GEOGRAPHIC REGION        
Northeast -- 300 -- 158
Midwest -- 261 -- 144
South -- 348 -- 134
West -- 334 -- 198
COUNTY TYPE        
Large Metro -- 745 -- 325
Small Metro -- 324 -- 194
Nonmetro -- 174 -- 114
Urbanized -- 44 -- 13
Less Urbanized -- 127 -- *
Completely Rural -- 3 -- *
POVERTY LEVEL2        
Less Than 100% -- 283 -- 174
100-199% -- 403 -- 156
200% or More -- 556 -- 303
HEALTH INSURANCE3        
Private -- 561 -- 309
Medicaid/CHIP -- 555 -- 262
Other4 -- 461 -- 216
No Coverage -- 106 -- 57
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Medication-assisted treatment for alcohol use refers to medication prescribed by a doctor or other health professional to help reduce or stop the use of alcohol.
1 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria.
2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.24B – Received Medication-Assisted Treatment (MAT) for Alcohol Use in Past Year: Among People Aged 12 or Older; Received MAT for Alcohol Use in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic Received MAT for
Alcohol Use
(2021)		 Received MAT for
Alcohol Use
(2022)		 Received MAT for
Alcohol Use among
People with an Alcohol
Use Disorder1
(2021)		 Received MAT for
Alcohol Use among
People with an Alcohol
Use Disorder1
(2022)
TOTAL -- 0.4 -- 2.1
GEOGRAPHIC REGION        
Northeast -- 0.6 -- 3.1
Midwest -- 0.4 -- 2.3
South -- 0.3 -- 1.3
West -- 0.5 -- 2.5
COUNTY TYPE        
Large Metro -- 0.5 -- 1.9
Small Metro -- 0.4 -- 2.0
Nonmetro -- 0.5 -- 3.5
Urbanized -- 0.3 -- 0.9
Less Urbanized -- 0.7 -- *
Completely Rural -- 0.1 -- *
POVERTY LEVEL2        
Less Than 100% -- 0.7 -- 4.0
100-199% -- 0.7 -- 3.0
200% or More -- 0.3 -- 1.5
HEALTH INSURANCE3        
Private -- 0.3 -- 1.7
Medicaid/CHIP -- 0.9 -- 4.6
Other4 -- 0.6 -- 4.2
No Coverage -- 0.4 -- 1.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Medication-assisted treatment for alcohol use refers to medication prescribed by a doctor or other health professional to help reduce or stop the use of alcohol.
1 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria.
2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.25A – Received Medication-Assisted Treatment (MAT) for Opioid Use in Past Year: Among People Aged 12 or Older; Received MAT for Opioid Use in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic Received MAT for
Opioid Use
(2021)		 Received MAT for
Opioid Use
(2022)		 Received MAT for
Opioid Use among
People with an
Opioid Use Disorder1
(2021)		 Received MAT for
Opioid Use among
People with an
Opioid Use Disorder1
(2022)
TOTAL -- 2,392 -- 1,121
GEOGRAPHIC REGION        
Northeast -- 523 -- 297
Midwest -- 483 -- 249
South -- 1,052 -- 427
West -- 335 -- 148
COUNTY TYPE        
Large Metro -- 1,286 -- 651
Small Metro -- 737 -- 343
Nonmetro -- 369 -- 128
Urbanized -- 144 -- 57
Less Urbanized -- 163 -- *
Completely Rural -- 63 -- *
POVERTY LEVEL2        
Less Than 100% -- 690 -- 384
100-199% -- 726 -- 360
200% or More -- 976 -- 378
HEALTH INSURANCE3        
Private -- 765 -- 300
Medicaid/CHIP -- 1,438 -- 786
Other4 -- 540 -- 250
No Coverage -- 183 -- *
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Medication-assisted treatment for opioid use refers to medication prescribed by a doctor or other health professional to help reduce or stop the use of opioids.
1 Opioid use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include opioid use disorder data from all past year users of opioids. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.25B – Received Medication-Assisted Treatment (MAT) for Opioid Use in Past Year: Among People Aged 12 or Older; Received MAT for Opioid Use in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic Received MAT for
Opioid Use
(2021)		 Received MAT for
Opioid Use
(2022)		 Received MAT for
Opioid Use among
People with an
Opioid Use Disorder1
(2021)		 Received MAT for
Opioid Use among
People with an
Opioid Use Disorder1
(2022)
TOTAL -- 0.8 -- 18.3
GEOGRAPHIC REGION        
Northeast -- 1.1 -- 29.0
Midwest -- 0.8 -- 18.3
South -- 1.0 -- 17.2
West -- 0.5 -- 11.9
COUNTY TYPE        
Large Metro -- 0.8 -- 20.3
Small Metro -- 0.8 -- 17.4
Nonmetro -- 1.0 -- 13.6
Urbanized -- 0.9 -- 15.1
Less Urbanized -- 0.9 -- *
Completely Rural -- 2.2 -- *
POVERTY LEVEL2        
Less Than 100% -- 1.7 -- 21.6
100-199% -- 1.3 -- 22.7
200% or More -- 0.5 -- 13.7
HEALTH INSURANCE3        
Private -- 0.4 -- 13.1
Medicaid/CHIP -- 2.4 -- 28.1
Other4 -- 0.7 -- 10.7
No Coverage -- 0.8 -- *
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Medication-assisted treatment for opioid use refers to medication prescribed by a doctor or other health professional to help reduce or stop the use of opioids.
1 Opioid use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include opioid use disorder data from all past year users of opioids. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.26A – Received Substance Use Treatment through Telehealth for Drug, Alcohol, and Drug or Alcohol Use: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Received Telehealth
Treatment for Drug Use
among People with a
Drug Use Disorder1
(2021)		 Received Telehealth
Treatment for Drug Use
among People with a
Drug Use Disorder1
(2022)		 Received Telehealth
Treatment for Alcohol
Use among People with
an Alcohol Use Disorder
(2021)		 Received Telehealth
Treatment for Alcohol
Use among People with
an Alcohol Use Disorder
(2022)		 Received Telehealth
Treatment for Drug or
Alcohol Use among
People with a Substance
Use Disorder1,2
(2021)		 Received Telehealth
Treatment for Drug or
Alcohol Use among
People with a Substance
Use Disorder1,2
(2022)
TOTAL -- 1,444 -- 1,084 -- 2,605
AGE GROUP            
12-17 -- 131 -- 29 -- 143
18 or Older -- 1,313 -- 1,055 -- 2,461
18-25 -- 199 -- 149 -- 354
26 or Older -- 1,114 -- 906 -- 2,108
GENDER            
Male -- 769 -- 646 -- 1,393
Female -- 675 -- 438 -- 1,212
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino -- 1,193 -- 949 -- 2,265
AIAN -- 15 -- 6 -- 19
Asian -- 8 -- * -- 32
Black or African American -- 106 -- 126 -- 274
NHOPI -- * -- * -- *
White -- 1,016 -- 788 -- 1,819
Two or More Races -- 47 -- 6 -- 74
Hispanic or Latino -- 251 -- 135 -- 340
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
2 Estimates include people who received treatment specifically for drugs or alcohol, as well as people who received treatment for unspecified substance(s).
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.26B – Received Substance Use Treatment through Telehealth for Drug, Alcohol, and Drug or Alcohol Use: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Received Telehealth
Treatment for Drug Use
among People with a
Drug Use Disorder1
(2021)		 Received Telehealth
Treatment for Drug Use
among People with a
Drug Use Disorder1
(2022)		 Received Telehealth
Treatment for Alcohol
Use among People with
an Alcohol Use Disorder
(2021)		 Received Telehealth
Treatment for Alcohol
Use among People with
an Alcohol Use Disorder
(2022)		 Received Telehealth
Treatment for Drug or
Alcohol Use among
People with a Substance
Use Disorder1,2
(2021)		 Received Telehealth
Treatment for Drug or
Alcohol Use among
People with a Substance
Use Disorder1,2
(2022)
TOTAL -- 5.3 -- 3.7 -- 5.3
AGE GROUP            
12-17 -- 7.2 -- 3.8 -- 6.4
18 or Older -- 5.2 -- 3.7 -- 5.3
18-25 -- 3.1 -- 2.6 -- 3.7
26 or Older -- 5.9 -- 3.9 -- 5.7
GENDER            
Male -- 5.1 -- 3.7 -- 5.0
Female -- 5.6 -- 3.6 -- 5.8
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino -- 5.4 -- 4.0 -- 5.7
AIAN -- 5.9 -- 3.9 -- 5.5
Asian -- 1.0 -- * -- 2.1
Black or African American -- 2.7 -- 3.5 -- 4.3
NHOPI -- * -- * -- *
White -- 6.4 -- 4.3 -- 6.1
Two or More Races -- 5.2 -- 1.0 -- 5.8
Hispanic or Latino -- 5.0 -- 2.5 -- 3.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
2 Estimates include people who received treatment specifically for drugs or alcohol, as well as people who received treatment for unspecified substance(s).
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.27A – Received Substance Use Treatment through Telehealth for Drug, Alcohol, and Drug or Alcohol Use: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021 and 2022
Geographic/Socioeconomic Characteristic Received Telehealth
Treatment for Drug Use
among People with a
Drug Use Disorder1
(2021)		 Received Telehealth
Treatment for Drug Use
among People with a
Drug Use Disorder1
(2022)		 Received Telehealth
Treatment for Alcohol
Use among People with
an Alcohol Use Disorder
(2021)		 Received Telehealth
Treatment for Alcohol
Use among People with
an Alcohol Use Disorder
(2022)		 Received Telehealth
Treatment for Drug or
Alcohol Use among
People with a Substance
Use Disorder1,2
(2021)		 Received Telehealth
Treatment for Drug or
Alcohol Use among
People with a Substance
Use Disorder1,2
(2022)
TOTAL -- 1,444 -- 1,084 -- 2,605
GEOGRAPHIC REGION            
Northeast -- 341 -- 167 -- 581
Midwest -- 370 -- 237 -- 578
South -- 489 -- 293 -- 779
West -- 244 -- 388 -- 667
COUNTY TYPE            
Large Metro -- 761 -- 520 -- 1,286
Small Metro -- 506 -- 327 -- 845
Nonmetro -- 177 -- 237 -- 474
Urbanized -- 66 -- 56 -- 206
Less Urbanized -- 103 -- * -- 260
Completely Rural -- * -- * -- *
POVERTY LEVEL3            
Less Than 100% -- 416 -- 238 -- 683
100-199% -- 417 -- 299 -- 715
200% or More -- 611 -- 547 -- 1,206
HEALTH INSURANCE4            
Private -- 502 -- 529 -- 1,001
Medicaid/CHIP -- 929 -- 475 -- 1,424
Other5 -- 269 -- 377 -- 610
No Coverage -- 76 -- 46 -- 140
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
2 Estimates include people who received treatment specifically for drugs or alcohol, as well as people who received treatment for unspecified substance(s).
3 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.27B – Received Substance Use Treatment through Telehealth for Drug, Alcohol, and Drug or Alcohol Use: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Geographic and Socioeconomic Characteristics, Percentages, 2021 and 2022
Geographic/Socioeconomic Characteristic Received Telehealth
Treatment for Drug Use
among People with a
Drug Use Disorder1
(2021)		 Received Telehealth
Treatment for Drug Use
among People with a
Drug Use Disorder1
(2022)		 Received Telehealth
Treatment for Alcohol
Use among People with
an Alcohol Use Disorder
(2021)		 Received Telehealth
Treatment for Alcohol
Use among People with
an Alcohol Use Disorder
(2022)		 Received Telehealth
Treatment for Drug or
Alcohol Use among
People with a Substance
Use Disorder1,2
(2021)		 Received Telehealth
Treatment for Drug or
Alcohol Use among
People with a Substance
Use Disorder1,2
(2022)
TOTAL -- 5.3 -- 3.7 -- 5.3
GEOGRAPHIC REGION            
Northeast -- 7.9 -- 3.2 -- 7.0
Midwest -- 6.5 -- 3.7 -- 5.5
South -- 5.1 -- 2.9 -- 4.6
West -- 3.2 -- 4.9 -- 5.2
COUNTY TYPE            
Large Metro -- 5.2 -- 3.1 -- 4.8
Small Metro -- 5.5 -- 3.4 -- 5.2
Nonmetro -- 5.4 -- 7.3 -- 8.5
Urbanized -- 4.6 -- 3.9 -- 8.4
Less Urbanized -- 6.7 -- * -- 9.6
Completely Rural -- * -- * -- *
POVERTY LEVEL3            
Less Than 100% -- 7.1 -- 5.5 -- 7.9
100-199% -- 6.2 -- 5.7 -- 7.0
200% or More -- 4.2 -- 2.8 -- 4.0
HEALTH INSURANCE4            
Private -- 3.9 -- 2.9 -- 3.7
Medicaid/CHIP -- 9.8 -- 8.3 -- 11.2
Other5 -- 5.0 -- 7.3 -- 6.5
No Coverage -- 2.5 -- 1.4 -- 2.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
2 Estimates include people who received treatment specifically for drugs or alcohol, as well as people who received treatment for unspecified substance(s).
3 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.28A – Types and Locations of Substance Use Treatment and Other Services in Past Year: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2021 and 2022
Type/Location of Treatment or Other Services Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
SUBSTANCE USE TREATMENT OR OTHER
SERVICES1		 -- 16,093 -- 1,287 -- 14,806 -- 1,963 -- 12,842
SUBSTANCE USE TREATMENT1 -- 13,106 -- 1,184 -- 11,922 -- 1,673 -- 10,248
Inpatient1 -- 3,488 -- 331 -- 3,158 -- 494 -- 2,664
Hospital1 -- 2,212 -- 178 -- 2,034 -- 336 -- 1,698
Residential Drug or Alcohol Rehab or
   Treatment Center1		 -- 1,600 -- 73 -- 1,526 -- 141 -- 1,386
Residential Mental Health Treatment Center1 -- 1,387 -- 181 -- 1,206 -- 242 -- 964
Some Other Place as an Inpatient1 -- 925 -- 99 -- 827 -- 146 -- 680
Outpatient1 -- 9,910 -- 952 -- 8,958 -- 1,203 -- 7,755
Drug or Alcohol Rehab or Treatment Center1 -- 2,247 -- 80 -- 2,168 -- 178 -- 1,989
Mental Health Treatment Center1 -- 2,688 -- 202 -- 2,486 -- 343 -- 2,143
Office of a Therapist, Psychologist, Psychiatrist, or
   Substance Use Treatment Professional1		 -- 5,483 -- 406 -- 5,077 -- 684 -- 4,393
General Medical Clinic or Doctor’s Office1 -- 5,313 -- 456 -- 4,857 -- 504 -- 4,353
Hospital1 -- 2,086 -- 170 -- 1,916 -- 194 -- 1,722
School’s Health or Counseling Center1 -- 1,090 -- 513 -- 577 -- 245 -- 332
Some Other Place as an Outpatient1 -- 844 -- 92 -- 752 -- 82 -- 670
Outpatient, Other Than General Medical Clinic or
   Doctor’s Office1		 -- 8,267 -- 792 -- 7,476 -- 1,038 -- 6,438
Medication-Assisted Treatment (MAT)                    
MAT for Alcohol Use -- 1,243 -- 44 -- 1,199 -- 95 -- 1,104
MAT for Opioid Use -- 2,392 -- 40 -- 2,353 -- 90 -- 2,262
Telehealth Treatment2 -- 3,575 -- 230 -- 3,345 -- 413 -- 2,932
Prison, Jail, or Juvenile Detention Center -- 721 -- 32 -- 689 -- 78 -- 611
OTHER SERVICES                    
Support Services                    
Support Group -- 5,770 -- 151 -- 5,619 -- 444 -- 5,175
Peer Support Specialist or Recovery Coach -- 2,003 -- 85 -- 1,918 -- 158 -- 1,760
Emergency Room/Department or Detoxification                    
Emergency Room/Department -- 1,996 -- 137 -- 1,859 -- 304 -- 1,555
Detoxification/Withdrawal Support Services -- 1,178 -- 44 -- 1,133 -- 91 -- 1,043
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
NOTE: Respondents could indicate multiple types/locations for receiving substance use treatment or other services; thus, these response categories are not mutually exclusive.
1 Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
2 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.28B – Types and Locations of Substance Use Treatment and Other Services in Past Year: Among People Aged 12 or Older; by Age Group, Percentages, 2021 and 2022
Type/Location of Treatment or Other Services Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
SUBSTANCE USE TREATMENT OR OTHER
SERVICES1		 -- 5.7 -- 5.0 -- 5.8 -- 5.6 -- 5.8
SUBSTANCE USE TREATMENT1 -- 4.6 -- 4.6 -- 4.7 -- 4.8 -- 4.6
Inpatient1 -- 1.2 -- 1.3 -- 1.2 -- 1.4 -- 1.2
Hospital1 -- 0.8 -- 0.7 -- 0.8 -- 1.0 -- 0.8
Residential Drug or Alcohol Rehab or
   Treatment Center1		 -- 0.6 -- 0.3 -- 0.6 -- 0.4 -- 0.6
Residential Mental Health Treatment Center1 -- 0.5 -- 0.7 -- 0.5 -- 0.7 -- 0.4
Some Other Place as an Inpatient1 -- 0.3 -- 0.4 -- 0.3 -- 0.4 -- 0.3
Outpatient1 -- 3.5 -- 3.7 -- 3.5 -- 3.5 -- 3.5
Drug or Alcohol Rehab or Treatment Center1 -- 0.8 -- 0.3 -- 0.8 -- 0.5 -- 0.9
Mental Health Treatment Center1 -- 1.0 -- 0.8 -- 1.0 -- 1.0 -- 1.0
Office of a Therapist, Psychologist, Psychiatrist, or
   Substance Use Treatment Professional1		 -- 1.9 -- 1.6 -- 2.0 -- 2.0 -- 2.0
General Medical Clinic or Doctor’s Office1 -- 1.9 -- 1.8 -- 1.9 -- 1.4 -- 2.0
Hospital1 -- 0.7 -- 0.7 -- 0.7 -- 0.6 -- 0.8
School’s Health or Counseling Center1 -- 0.4 -- 2.0 -- 0.2 -- 0.7 -- 0.1
Some Other Place as an Outpatient1 -- 0.3 -- 0.4 -- 0.3 -- 0.2 -- 0.3
Outpatient, Other Than General Medical Clinic or
   Doctor’s Office1		 -- 2.9 -- 3.1 -- 2.9 -- 3.0 -- 2.9
Medication-Assisted Treatment (MAT)                    
MAT for Alcohol Use -- 0.4 -- 0.2 -- 0.5 -- 0.3 -- 0.5
MAT for Opioid Use -- 0.8 -- 0.2 -- 0.9 -- 0.3 -- 1.0
Telehealth Treatment2 -- 1.3 -- 0.9 -- 1.3 -- 1.2 -- 1.3
Prison, Jail, or Juvenile Detention Center -- 0.3 -- 0.1 -- 0.3 -- 0.2 -- 0.3
OTHER SERVICES                    
Support Services                    
Support Group -- 2.0 -- 0.6 -- 2.2 -- 1.3 -- 2.3
Peer Support Specialist or Recovery Coach -- 0.7 -- 0.3 -- 0.7 -- 0.5 -- 0.8
Emergency Room/Department or Detoxification                    
Emergency Room/Department -- 0.7 -- 0.5 -- 0.7 -- 0.9 -- 0.7
Detoxification/Withdrawal Support Services -- 0.4 -- 0.2 -- 0.4 -- 0.3 -- 0.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
NOTE: Respondents could indicate multiple types/locations for receiving substance use treatment or other services; thus, these response categories are not mutually exclusive.
1 Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
2 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.29A – Substances for Which Treatment Was Received as an Inpatient and Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances, Numbers in Thousands, 2021 and 2022
Substance for Which Treatment Was Received and
Use Disorder for Specific Substance		 Inpatient
(2021)		 Inpatient
(2022)		 Outpatient
(2021)		 Outpatient
(2022)
DRUGS OR ALCOHOL1,2 -- 2,245 -- 5,406
DRUGS1 -- 965 -- 2,227
Marijuana -- 202 -- 530
Cocaine -- 151 -- 217
Heroin -- * -- 340
Hallucinogens -- 20 -- 35
Inhalants -- * -- *
Methamphetamine -- 161 -- 282
Prescription Psychotherapeutics1 -- 339 -- 780
Pain Relievers1 -- 228 -- 505
Stimulants1 -- 52 -- 119
Tranquilizers or Sedatives1 -- 63 -- 166
Tranquilizers1 -- 36 -- 133
Sedatives1 -- 29 -- 41
Opioids1 -- 489 -- 884
Central Nervous System Stimulants1 -- 319 -- 569
ALCOHOL -- 744 -- 1,445
BOTH DRUGS AND ALCOHOL1 -- 168 -- 337
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
2 These estimates include data from respondents who reported that they received inpatient or outpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.29B – Substances for Which Treatment Was Received as an Inpatient and Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances, Percentages, 2021 and 2022
Substance for Which Treatment Was Received and
Use Disorder for Specific Substance		 Inpatient
(2021)		 Inpatient
(2022)		 Outpatient
(2021)		 Outpatient
(2022)
DRUGS OR ALCOHOL1,2 -- 4.6 -- 11.1
DRUGS1 -- 3.5 -- 8.2
Marijuana -- 1.1 -- 2.8
Cocaine -- 10.5 -- 15.1
Heroin -- * -- 37.8
Hallucinogens -- 3.4 -- 5.8
Inhalants -- * -- *
Methamphetamine -- 8.8 -- 15.4
Prescription Psychotherapeutics1 -- 4.1 -- 9.5
Pain Relievers1 -- 4.1 -- 9.0
Stimulants1 -- 2.9 -- 6.5
Tranquilizers or Sedatives1 -- 2.7 -- 7.0
Tranquilizers1 -- 2.0 -- 7.4
Sedatives1 -- 3.4 -- 4.9
Opioids1 -- 8.0 -- 14.4
Central Nervous System Stimulants1 -- 7.1 -- 12.6
ALCOHOL -- 2.5 -- 4.9
BOTH DRUGS AND ALCOHOL1 -- 2.1 -- 4.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
2 These estimates include data from respondents who reported that they received inpatient or outpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.30A – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Numbers in Thousands, 2021 and 2022
Substance for Which Treatment Was
Received and Use Disorder for Specific
Substance		 Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
DRUGS OR ALCOHOL1,2 -- 2,245 -- 163 -- 2,083 -- 358 -- 1,725
DRUGS1 -- 965 -- 94 -- 871 -- 160 -- 711
Marijuana -- 202 -- 55 -- 148 -- 59 -- 88
Cocaine -- 151 -- * -- 150 -- 10 -- *
Heroin -- * -- * -- * -- * -- *
Hallucinogens -- 20 -- * -- 10 -- 8 -- *
Inhalants -- * -- * -- * -- * -- *
Methamphetamine -- 161 -- * -- 159 -- * -- 141
Prescription Psychotherapeutics1 -- 339 -- 44 -- 296 -- 46 -- 250
Pain Relievers1 -- 228 -- 13 -- 215 -- 32 -- 183
Stimulants1 -- 52 -- * -- 36 -- 7 -- *
Tranquilizers or Sedatives1 -- 63 -- * -- 49 -- 7 -- 42
Tranquilizers1 -- 36 -- * -- 35 -- 6 -- 29
Sedatives1 -- 29 -- * -- * -- * -- *
Opioids1 -- 489 -- 13 -- 475 -- 41 -- 435
Central Nervous System Stimulants1 -- 319 -- 18 -- 301 -- 35 -- 266
ALCOHOL -- 744 -- 20 -- 724 -- 110 -- 614
BOTH DRUGS AND ALCOHOL1 -- 168 -- 6 -- 162 -- 47 -- 114
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
2 These estimates include data from respondents who reported that they received inpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.30B – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Percentages, 2021 and 2022
Substance for Which Treatment Was
Received and Use Disorder for Specific
Substance		 Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
DRUGS OR ALCOHOL1,2 -- 4.6 -- 7.3 -- 4.5 -- 3.7 -- 4.7
DRUGS1 -- 3.5 -- 5.2 -- 3.4 -- 2.5 -- 3.8
Marijuana -- 1.1 -- 4.2 -- 0.8 -- 1.0 -- 0.7
Cocaine -- 10.5 -- * -- 10.5 -- 3.9 -- *
Heroin -- * -- * -- * -- * -- *
Hallucinogens -- 3.4 -- * -- 2.0 -- 3.6 -- *
Inhalants -- * -- * -- * -- * -- *
Methamphetamine -- 8.8 -- * -- 8.8 -- * -- 8.1
Prescription Psychotherapeutics1 -- 4.1 -- 8.1 -- 3.8 -- 4.9 -- 3.7
Pain Relievers1 -- 4.1 -- 5.0 -- 4.0 -- 7.7 -- 3.7
Stimulants1 -- 2.9 -- * -- 2.3 -- 1.4 -- *
Tranquilizers or Sedatives1 -- 2.7 -- * -- 2.2 -- 2.4 -- 2.2
Tranquilizers1 -- 2.0 -- * -- 2.0 -- 2.4 -- 1.9
Sedatives1 -- 3.4 -- * -- * -- * -- *
Opioids1 -- 8.0 -- 5.0 -- 8.1 -- 9.6 -- 8.0
Central Nervous System Stimulants1 -- 7.1 -- 6.8 -- 7.1 -- 4.6 -- 7.6
ALCOHOL -- 2.5 -- 2.7 -- 2.5 -- 1.9 -- 2.7
BOTH DRUGS AND ALCOHOL1 -- 2.1 -- 1.9 -- 2.1 -- 1.9 -- 2.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
2 These estimates include data from respondents who reported that they received inpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.31A – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Numbers in Thousands, 2021 and 2022
Substance for Which Treatment Was
Received and Use Disorder for Specific
Substance		 Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
DRUGS OR ALCOHOL1,2 -- 5,406 -- 365 -- 5,041 -- 818 -- 4,223
DRUGS1 -- 2,227 -- 199 -- 2,027 -- 298 -- 1,730
Marijuana -- 530 -- 134 -- 396 -- 147 -- 248
Cocaine -- 217 -- * -- 216 -- 21 -- 194
Heroin -- 340 -- * -- 340 -- * -- *
Hallucinogens -- 35 -- * -- 15 -- * -- *
Inhalants -- * -- * -- * -- * -- *
Methamphetamine -- 282 -- * -- 278 -- * -- 261
Prescription Psychotherapeutics1 -- 780 -- 66 -- 714 -- 86 -- 629
Pain Relievers1 -- 505 -- 36 -- 469 -- 46 -- 423
Stimulants1 -- 119 -- 28 -- 91 -- 23 -- 68
Tranquilizers or Sedatives1 -- 166 -- * -- 153 -- 19 -- 134
Tranquilizers1 -- 133 -- * -- 127 -- * -- 110
Sedatives1 -- 41 -- * -- 38 -- * -- *
Opioids1 -- 884 -- 36 -- 848 -- 55 -- 793
Central Nervous System Stimulants1 -- 569 -- 34 -- 535 -- 58 -- 477
ALCOHOL -- 1,445 -- 30 -- 1,416 -- 198 -- 1,218
BOTH DRUGS AND ALCOHOL1 -- 337 -- 19 -- 318 -- 51 -- 267
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
2 These estimates include data from respondents who reported that they received outpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.31B – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Percentages, 2021 and 2022
Substance for Which Treatment Was
Received and Use Disorder for Specific
Substance		 Aged 12+
(2021)		 Aged 12+
(2022)		 Aged 12-17
(2021)		 Aged 12-17
(2022)		 Aged 18+
(2021)		 Aged 18+
(2022)		 Aged 18-25
(2021)		 Aged 18-25
(2022)		 Aged 26+
(2021)		 Aged 26+
(2022)
DRUGS OR ALCOHOL1,2 -- 11.1 -- 16.4 -- 10.8 -- 8.5 -- 11.5
DRUGS1 -- 8.2 -- 11.0 -- 8.0 -- 4.6 -- 9.1
Marijuana -- 2.8 -- 10.3 -- 2.2 -- 2.6 -- 2.1
Cocaine -- 15.1 -- * -- 15.1 -- 8.0 -- 16.7
Heroin -- 37.8 -- * -- 37.9 -- * -- *
Hallucinogens -- 5.8 -- * -- 2.9 -- * -- *
Inhalants -- * -- * -- * -- * -- *
Methamphetamine -- 15.4 -- * -- 15.3 -- * -- 15.0
Prescription Psychotherapeutics1 -- 9.5 -- 12.2 -- 9.3 -- 9.1 -- 9.3
Pain Relievers1 -- 9.0 -- 13.5 -- 8.8 -- 11.1 -- 8.6
Stimulants1 -- 6.5 -- 10.7 -- 5.8 -- 4.9 -- 6.2
Tranquilizers or Sedatives1 -- 7.0 -- * -- 6.9 -- 6.4 -- 7.0
Tranquilizers1 -- 7.4 -- * -- 7.3 -- * -- 7.3
Sedatives1 -- 4.9 -- * -- 4.9 -- * -- *
Opioids1 -- 14.4 -- 13.5 -- 14.5 -- 13.0 -- 14.6
Central Nervous System Stimulants1 -- 12.6 -- 12.8 -- 12.6 -- 7.7 -- 13.7
ALCOHOL -- 4.9 -- 3.9 -- 4.9 -- 3.5 -- 5.3
BOTH DRUGS AND ALCOHOL1 -- 4.2 -- 5.7 -- 4.1 -- 2.0 -- 5.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
2 These estimates include data from respondents who reported that they received outpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.32A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Past Year Drug Use Disorder, Past Year Alcohol Use Disorder, Past Year Drug and Alcohol Use Disorder, and Past Year Substance Use Disorder, Numbers in Thousands, 2021 and 2022
Substance Use Disorder Status/Age Group Treatment
for Drugs
(2021)		 Treatment
for Drugs
(2022)		 Treatment
for Alcohol
(2021)		 Treatment
for Alcohol
(2022)		 Treatment
for Both
Drugs and
Alcohol
(2021)		 Treatment
for Both
Drugs and
Alcohol
(2022)		 Treatment
for Substance
Unspecified1
(2021)		 Treatment
for Substance
Unspecified1
(2022)		 Treatment
for Drugs
or Alcohol1
(2021)		 Treatment
for Drugs
or Alcohol1
(2022)
DRUGS2 -- 3,569 -- 1,581 -- 1,084 -- 1,324 -- 5,390
12-17 -- 292 -- 73 -- 59 -- 115 -- 420
18 or Older -- 3,277 -- 1,509 -- 1,025 -- 1,209 -- 4,970
18-25 -- 515 -- 273 -- 163 -- 312 -- 937
26 or Older -- 2,763 -- 1,236 -- 862 -- 896 -- 4,033
ALCOHOL -- 1,407 -- 2,247 -- 795 -- 792 -- 3,651
12-17 -- 86 -- 54 -- 39 -- 46 -- 148
18 or Older -- 1,321 -- 2,193 -- 756 -- 746 -- 3,504
18-25 -- 294 -- 306 -- 145 -- 161 -- 617
26 or Older -- 1,027 -- 1,887 -- 612 -- 584 -- 2,886
BOTH DRUGS AND ALCOHOL2 -- 1,037 -- 884 -- 560 -- 428 -- 1,789
12-17 -- 78 -- 41 -- 34 -- * -- 115
18 or Older -- 959 -- 843 -- 526 -- 398 -- 1,674
18-25 -- 230 -- 168 -- 107 -- 100 -- 390
26 or Older -- 729 -- 675 -- 419 -- 298 -- 1,283
DRUGS OR ALCOHOL2 -- 3,940 -- 2,944 -- 1,319 -- 1,688 -- 7,253
12-17 -- 300 -- 85 -- 64 -- 132 -- 453
18 or Older -- 3,640 -- 2,859 -- 1,255 -- 1,556 -- 6,800
18-25 -- 580 -- 411 -- 201 -- 374 -- 1,164
26 or Older -- 3,060 -- 2,448 -- 1,054 -- 1,182 -- 5,636
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
1 These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
2 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.32B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Past Year Drug Use Disorder, Past Year Alcohol Use Disorder, Past Year Drug and Alcohol Use Disorder, and Past Year Substance Use Disorder, Percentages, 2021 and 2022
Substance Use Disorder Status/Age Group Treatment
for Drugs
(2021)		 Treatment
for Drugs
(2022)		 Treatment
for Alcohol
(2021)		 Treatment
for Alcohol
(2022)		 Treatment
for Both
Drugs and
Alcohol
(2021)		 Treatment
for Both
Drugs and
Alcohol
(2022)		 Treatment
for Substance
Unspecified1
(2021)		 Treatment
for Substance
Unspecified1
(2022)		 Treatment
for Drugs
or Alcohol1
(2021)		 Treatment
for Drugs
or Alcohol1
(2022)
DRUGS2 -- 13.1 -- 5.8 -- 4.0 -- 4.9 -- 19.8
12-17 -- 16.1 -- 4.0 -- 3.3 -- 6.3 -- 23.2
18 or Older -- 12.9 -- 5.9 -- 4.0 -- 4.8 -- 19.6
18-25 -- 7.9 -- 4.2 -- 2.5 -- 4.8 -- 14.5
26 or Older -- 14.6 -- 6.5 -- 4.6 -- 4.7 -- 21.3
ALCOHOL -- 4.8 -- 7.6 -- 2.7 -- 2.7 -- 12.4
12-17 -- 11.4 -- 7.2 -- 5.2 -- 6.1 -- 19.6
18 or Older -- 4.6 -- 7.6 -- 2.6 -- 2.6 -- 12.2
18-25 -- 5.2 -- 5.4 -- 2.5 -- 2.8 -- 10.9
26 or Older -- 4.4 -- 8.2 -- 2.6 -- 2.5 -- 12.5
BOTH DRUGS AND ALCOHOL2 -- 12.9 -- 11.0 -- 7.0 -- 5.3 -- 22.2
12-17 -- 23.0 -- 12.2 -- 10.0 -- * -- 34.0
18 or Older -- 12.4 -- 10.9 -- 6.8 -- 5.2 -- 21.7
18-25 -- 9.2 -- 6.7 -- 4.3 -- 4.0 -- 15.6
26 or Older -- 14.0 -- 13.0 -- 8.0 -- 5.7 -- 24.6
DRUGS OR ALCOHOL2 -- 8.1 -- 6.0 -- 2.7 -- 3.5 -- 14.9
12-17 -- 13.5 -- 3.8 -- 2.9 -- 5.9 -- 20.3
18 or Older -- 7.8 -- 6.1 -- 2.7 -- 3.3 -- 14.6
18-25 -- 6.0 -- 4.3 -- 2.1 -- 3.9 -- 12.0
26 or Older -- 8.3 -- 6.6 -- 2.9 -- 3.2 -- 15.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria.
1 These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
2 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.33A – Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older with Substance Use Disorder in Past Year; by Substance Use Disorder Severity Level and Age Group, Numbers in Thousands, 2021 and 2022
Substance Use Disorder
Severity Level/Age Group		 Among People Aged 12 or Older with Substance Use Disorder in Past Year
Received
Substance Use
Treatment
(SU Tx)1
(2021)		 Received
Substance Use
Treatment
(SU Tx)1
(2022)		 Did Not Receive
SU Tx1
(2021)		 Did Not Receive
SU Tx1
(2022)		 Received SU Tx
or Other
Services1,2
(2021)		 Received SU Tx
or Other
Services1,2
(2022)		 Did Not Receive
SU Tx or Other
Services1,2
(2021)		 Did Not Receive
SU Tx or Other
Services1,2
(2022)
Any SUD -- 7,253 -- 41,469 -- 8,351 -- 40,371
12-17 -- 453 -- 1,775 -- 488 -- 1,740
18 or Older -- 6,800 -- 39,694 -- 7,863 -- 38,631
18-25 -- 1,164 -- 8,505 -- 1,361 -- 8,307
26 or Older -- 5,636 -- 31,190 -- 6,502 -- 30,323
Mild SUD -- 2,218 -- 24,594 -- 2,607 -- 24,205
12-17 -- 157 -- 1,038 -- 167 -- 1,028
18 or Older -- 2,061 -- 23,555 -- 2,440 -- 23,177
18-25 -- 328 -- 4,224 -- 375 -- 4,178
26 or Older -- 1,733 -- 19,331 -- 2,065 -- 18,999
Moderate SUD -- 1,524 -- 9,501 -- 1,725 -- 9,300
12-17 -- 112 -- 435 -- 119 -- 427
18 or Older -- 1,412 -- 9,066 -- 1,605 -- 8,873
18-25 -- 229 -- 2,357 -- 289 -- 2,298
26 or Older -- 1,183 -- 6,708 -- 1,316 -- 6,575
Severe SUD -- 3,511 -- 7,375 -- 4,020 -- 6,866
12-17 -- 185 -- 302 -- 201 -- 285
18 or Older -- 3,326 -- 7,073 -- 3,818 -- 6,581
18-25 -- 606 -- 1,923 -- 697 -- 1,832
26 or Older -- 2,720 -- 5,150 -- 3,121 -- 4,749
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents were classified as needing substance use treatment if they met DSM-5 criteria for a drug or alcohol use disorder or received treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
1 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
2 Other services includes treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; or detoxification/withdrawal support services. Other services questions are asked of respondents who used alcohol or drugs in their lifetime.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.33B – Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older with Substance Use Disorder in Past Year; by Substance Use Disorder Severity Level and Age Group, Percentages, 2021 and 2022
Substance Use Disorder
Severity Level/Age Group		 Among People Aged 12 or Older with Substance Use Disorder in Past Year
Received
Substance Use
Treatment
(SU Tx)1
(2021)		 Received
Substance Use
Treatment
(SU Tx)1
(2022)		 Did Not Receive
SU Tx1
(2021)		 Did Not Receive
SU Tx1
(2022)		 Received SU Tx
or Other
Services1,2
(2021)		 Received SU Tx
or Other
Services1,2
(2022)		 Did Not Receive
SU Tx or Other
Services1,2
(2021)		 Did Not Receive
SU Tx or Other
Services1,2
(2022)
Any SUD -- 14.9 -- 85.1 -- 17.1 -- 82.9
12-17 -- 20.3 -- 79.7 -- 21.9 -- 78.1
18 or Older -- 14.6 -- 85.4 -- 16.9 -- 83.1
18-25 -- 12.0 -- 88.0 -- 14.1 -- 85.9
26 or Older -- 15.3 -- 84.7 -- 17.7 -- 82.3
Mild SUD -- 8.3 -- 91.7 -- 9.7 -- 90.3
12-17 -- 13.1 -- 86.9 -- 14.0 -- 86.0
18 or Older -- 8.0 -- 92.0 -- 9.5 -- 90.5
18-25 -- 7.2 -- 92.8 -- 8.2 -- 91.8
26 or Older -- 8.2 -- 91.8 -- 9.8 -- 90.2
Moderate SUD -- 13.8 -- 86.2 -- 15.6 -- 84.4
12-17 -- 20.4 -- 79.6 -- 21.8 -- 78.2
18 or Older -- 13.5 -- 86.5 -- 15.3 -- 84.7
18-25 -- 8.9 -- 91.1 -- 11.2 -- 88.8
26 or Older -- 15.0 -- 85.0 -- 16.7 -- 83.3
Severe SUD -- 32.3 -- 67.7 -- 36.9 -- 63.1
12-17 -- 38.0 -- 62.0 -- 41.4 -- 58.6
18 or Older -- 32.0 -- 68.0 -- 36.7 -- 63.3
18-25 -- 24.0 -- 76.0 -- 27.6 -- 72.4
26 or Older -- 34.6 -- 65.4 -- 39.7 -- 60.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents were classified as needing substance use treatment if they met DSM-5 criteria for a drug or alcohol use disorder or received treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
1 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
2 Other services includes treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; or detoxification/withdrawal support services. Other services questions are asked of respondents who used alcohol or drugs in their lifetime.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230919
Table 5.34A – Classified as Needing Substance Use Treatment: Among People Aged 12 or Older; Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older Classified as Needing Substance Use Treatment in Past Year; by Demographic Characteristics, Numbers in Thousands and Percentages, 2021 and 2022
Demographic Characteristic Among the Total Population Among People Classified as Needing Substance Use Treatment (SU Tx)
Classified as
Needing SU Tx
(2021)		 Classified as
Needing SU Tx
(2022)		 % Who Received
SU Tx1
(2021)		 % Who Received
SU Tx1
(2022)		 % Who Did Not
Receive SU Tx1
(2021)		 % Who Did Not
Receive SU Tx1
(2022)		 % Who Received
SU Tx or Other
Services1,2
(2021)		 % Who Received
SU Tx or Other
Services1,2
(2022)		 %Who Did Not
Receive SU Tx or
Other Services1,2
(2021)		 %Who Did Not
Receive SU Tx or
Other Services1,2
(2022)
TOTAL -- 54,575 -- 24.0 -- 76.0 -- 26.0 -- 74.0
AGE GROUP                    
12-17 -- 2,960 -- 40.0 -- 60.0 -- 41.2 -- 58.8
18 or Older -- 51,616 -- 23.1 -- 76.9 -- 25.2 -- 74.8
18-25 -- 10,178 -- 16.4 -- 83.6 -- 18.4 -- 81.6
26 or Older -- 41,438 -- 24.7 -- 75.3 -- 26.8 -- 73.2
GENDER                    
Male -- 30,873 -- 23.5 -- 76.5 -- 25.6 -- 74.4
Female -- 23,702 -- 24.7 -- 75.3 -- 26.6 -- 73.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino -- 44,688 -- 24.6 -- 75.4 -- 26.6 -- 73.4
AIAN -- 410 -- * -- * -- * -- *
Asian -- 1,705 -- * -- * -- * -- *
Black or African American -- 7,023 -- 22.5 -- 77.5 -- 24.7 -- 75.3
NHOPI -- * -- * -- * -- * -- *
White -- 33,798 -- 24.9 -- 75.1 -- 26.9 -- 73.1
Two or More Races -- 1,415 -- 24.6 -- 75.4 -- 28.1 -- 71.9
Hispanic or Latino -- 9,887 -- 21.4 -- 78.6 -- 23.5 -- 76.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Respondents were classified as needing substance use treatment if they met DSM-5 criteria for a drug or alcohol use disorder or received treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
1 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
2 Other services includes treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; or detoxification/withdrawal support services. Other services questions are asked of respondents who used alcohol or drugs in their lifetime.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230919
Table 5.34B – Classified as Needing Substance Use Treatment: Among People Aged 12 or Older; Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older Classified as Needing Substance Use Treatment in Past Year; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Among the Total Population Among People Classified as Needing Substance Use Treatment (SU Tx)
Classified as
Needing SU Tx
(2021)		 Classified as
Needing SU Tx
(2022)		 % Who Received
SU Tx1
(2021)		 % Who Received
SU Tx1
(2022)		 % Who Did Not
Receive SU Tx1
(2021)		 % Who Did Not
Receive SU Tx1
(2022)		 % Who Received
SU Tx or Other
Services1,2
(2021)		 % Who Received
SU Tx or Other
Services1,2
(2022)		 %Who Did Not
Receive SU Tx or
Other Services1,2
(2021)		 %Who Did Not
Receive SU Tx or
Other Services1,2
(2022)
TOTAL -- 19.4 -- 24.0 -- 76.0 -- 26.0 -- 74.0
AGE GROUP                    
12-17 -- 11.5 -- 40.0 -- 60.0 -- 41.2 -- 58.8
18 or Older -- 20.1 -- 23.1 -- 76.9 -- 25.2 -- 74.8
18-25 -- 29.3 -- 16.4 -- 83.6 -- 18.4 -- 81.6
26 or Older -- 18.7 -- 24.7 -- 75.3 -- 26.8 -- 73.2
GENDER                    
Male -- 22.3 -- 23.5 -- 76.5 -- 25.6 -- 74.4
Female -- 16.5 -- 24.7 -- 75.3 -- 26.6 -- 73.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino -- 19.3 -- 24.6 -- 75.4 -- 26.6 -- 73.4
AIAN -- 28.0 -- * -- * -- * -- *
Asian -- 10.0 -- * -- * -- * -- *
Black or African American -- 20.4 -- 22.5 -- 77.5 -- 24.7 -- 75.3
NHOPI -- * -- * -- * -- * -- *
White -- 19.8 -- 24.9 -- 75.1 -- 26.9 -- 73.1
Two or More Races -- 24.1 -- 24.6 -- 75.4 -- 28.1 -- 71.9
Hispanic or Latino -- 19.4 -- 21.4 -- 78.6 -- 23.5 -- 76.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Respondents were classified as needing substance use treatment if they met DSM-5 criteria for a drug or alcohol use disorder or received treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
1 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
2 Other services includes treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; or detoxification/withdrawal support services. Other services questions are asked of respondents who used alcohol or drugs in their lifetime.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.35A – Sought or Thought Should Get Substance Use Treatment in Past Year: Among People Aged 12 or Older with a Past Year Drug or Alcohol Use Disorder Who Did Not Receive Substance Use Treatment in Past Year; by Demographic Characteristics, Numbers in Thousands, 2021 and 2022
Demographic Characteristic Among People Aged 12 or Older with a Past Year Drug or Alcohol Use Disorder
Who Did Not Receive Substance Use Treatment in Past Year
Sought or
Thought Should
Get Treatment
(2021)		 Sought or
Thought Should
Get Treatment
(2022)		 Sought
Treatment
(2021)		 Sought
Treatment
(2022)		 Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2021)		 Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2022)		 Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2021)		 Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2022)
TOTAL -- 2,120 -- 321 -- 1,800 -- 38,470
AGE GROUP                
12-17 -- 42 -- 8 -- 34 -- 1,665
18 or Older -- 2,079 -- 313 -- 1,766 -- 36,805
18-25 -- 410 -- 32 -- 377 -- 7,958
26 or Older -- 1,669 -- 280 -- 1,389 -- 28,847
GENDER                
Male -- 1,063 -- 142 -- 921 -- 22,020
Female -- 1,057 -- 179 -- 879 -- 16,450
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino -- 1,617 -- 179 -- 1,439 -- 31,348
AIAN -- * -- * -- * -- *
Asian -- 49 -- 19 -- 30 -- 1,212
Black or African American -- 246 -- 5 -- 241 -- 5,061
NHOPI -- * -- * -- * -- *
White -- 1,230 -- 139 -- 1,091 -- 23,639
Two or More Races -- 70 -- * -- 62 -- 973
Hispanic or Latino -- 503 -- 142 -- 361 -- 7,122
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information for whether they sought or thought they should get substance use treatment were excluded.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.35B – Sought or Thought Should Get Substance Use Treatment in Past Year: Among People Aged 12 or Older with a Past Year Drug or Alcohol Use Disorder Who Did Not Receive Substance Use Treatment in Past Year; by Demographic Characteristics, Percentages, 2021 and 2022
Demographic Characteristic Among People Aged 12 or Older with a Past Year Drug or Alcohol Use Disorder
Who Did Not Receive Substance Use Treatment in Past Year
Sought or
Thought Should
Get Treatment
(2021)		 Sought or
Thought Should
Get Treatment
(2022)		 Sought
Treatment
(2021)		 Sought
Treatment
(2022)		 Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2021)		 Thought
Should Get
Treatment but
Did Not Seek
Treatment
(2022)		 Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2021)		 Did Not Seek
Treatment and
Did Not Think
Should Get
Treatment
(2022)
TOTAL -- 5.2 -- 0.8 -- 4.4 -- 94.8
AGE GROUP                
12-17 -- 2.5 -- 0.5 -- 2.0 -- 97.5
18 or Older -- 5.3 -- 0.8 -- 4.5 -- 94.7
18-25 -- 4.9 -- 0.4 -- 4.5 -- 95.1
26 or Older -- 5.5 -- 0.9 -- 4.6 -- 94.5
GENDER                
Male -- 4.6 -- 0.6 -- 4.0 -- 95.4
Female -- 6.0 -- 1.0 -- 5.0 -- 94.0
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino -- 4.9 -- 0.5 -- 4.4 -- 95.1
AIAN -- * -- * -- * -- *
Asian -- 3.9 -- 1.5 -- 2.4 -- 96.1
Black or African American -- 4.6 -- 0.1 -- 4.5 -- 95.4
NHOPI -- * -- * -- * -- *
White -- 4.9 -- 0.6 -- 4.4 -- 95.1
Two or More Races -- 6.7 -- * -- 5.9 -- 93.3
Hispanic or Latino -- 6.6 -- 1.9 -- 4.7 -- 93.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents with unknown information for whether they sought or thought they should get substance use treatment were excluded.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.36A – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year: Among People Aged 12 or Older Who Did Not Receive Substance Use Treatment and Sought or Thought Should Get Substance Use Treatment in Past Year; by Past Year Sought Treatment Status, Numbers in Thousands, 2021 and 2022
Reason for Not Receiving Substance Use Treatment Among People Aged 12 or Older Who Did Not Receive Substance Use Treatment
and Sought or Thought Should Get Substance Use Treatment in Past Year
Sought or Thought
Should Get
Treatment
(2021)		 Sought or Thought
Should Get
Treatment
(2022)		 Sought
Treatment
(2021)		 Sought
Treatment
(2022)		 Thought Should Get
Treatment but Did
Not Seek Treatment
(2021)		 Thought Should Get
Treatment but Did
Not Seek Treatment
(2022)
Thought It Would Cost Too Much -- 1,059 -- * -- 937
Did Not Have Health Insurance Coverage for Alcohol or Drug
   Use Treatment		 -- 895 -- * -- 711
Health Insurance Would Not Pay Enough of Costs for Treatment -- 739 -- * -- 618
Did Not Know How or Where to Get Treatment -- 1,133 -- * -- 919
Could Not Find Treatment Program or Healthcare Professional
   They Wanted to Go to		 -- 806 -- * -- 629
No Openings in Treatment Program or with Healthcare Professional
   They Wanted to Go to		 -- 270 -- * -- 181
Had Problems with Things Like Transportation, Childcare, or Getting
   Appointments at Times that Worked for Them		 -- 519 -- * -- 455
Did Not Have Enough Time for Treatment -- 918 -- * -- 753
Worried That Information Would Not Be Kept Private -- 810 -- * -- 689
Worried about What People Would Think or Say if They
   Got Treatment		 -- 998 -- * -- 876
Thought That if People Knew They Were in Treatment, Bad
   Things Would Happen, Like Losing Their Job, Home, or Children		 -- 810 -- * -- 715
Not Ready to Start Treatment -- 1,431 -- * -- 1,223
Not Ready to Stop or Cut Back Using Alcohol or Drugs -- 1,207 -- * -- 1,023
Thought They Should Have Been Able to Handle Their Alcohol
   or Drug Use on Their Own		 -- 1,721 -- * -- 1,502
Thought Their Family, Friends, or Religious Group Would Not
   Like It if They Got Treatment		 -- 387 -- * -- 341
Thought They Would Be Forced to Stay in Rehab or Treatment
   against Their Will		 -- 538 -- * -- 491
Did Not Think Treatment Would Help Them -- 604 -- * -- 522
Thought No One Would Care if They Got Better -- 419 -- * -- 383
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents could indicate multiple reasons for not receiving substance use treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving substance use treatment data were excluded.
NOTE: Respondents with unknown information for whether they sought or thought they should get substance use treatment were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.
230801
Table 5.36B – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year: Among People Aged 12 or Older Who Did Not Receive Substance Use Treatment and Sought or Thought Should Get Substance Use Treatment in Past Year; by Past Year Sought Treatment Status, Percentages, 2021 and 2022
Reason for Not Receiving Substance Use Treatment Among People Aged 12 or Older Who Did Not Receive Substance Use Treatment
and Sought or Thought Should Get Substance Use Treatment in Past Year
Sought or Thought
Should Get
Treatment
(2021)		 Sought or Thought
Should Get
Treatment
(2022)		 Sought
Treatment
(2021)		 Sought
Treatment
(2022)		 Thought Should Get
Treatment but Did
Not Seek Treatment
(2021)		 Thought Should Get
Treatment but Did
Not Seek Treatment
(2022)
Thought It Would Cost Too Much -- 45.6 -- * -- 49.2
Did Not Have Health Insurance Coverage for Alcohol or Drug
   Use Treatment		 -- 39.1 -- * -- 38.0
Health Insurance Would Not Pay Enough of Costs for Treatment -- 33.8 -- * -- 34.4
Did Not Know How or Where to Get Treatment -- 48.2 -- * -- 47.5
Could Not Find Treatment Program or Healthcare Professional
   They Wanted to Go to		 -- 35.1 -- * -- 33.4
No Openings in Treatment Program or with Healthcare Professional
   They Wanted to Go to		 -- 11.9 -- * -- 9.8
Had Problems with Things Like Transportation, Childcare, or Getting
   Appointments at Times that Worked for Them		 -- 22.2 -- * -- 23.7
Did Not Have Enough Time for Treatment -- 39.6 -- * -- 39.5
Worried That Information Would Not Be Kept Private -- 34.9 -- * -- 35.8
Worried about What People Would Think or Say if They
   Got Treatment		 -- 42.4 -- * -- 45.3
Thought That if People Knew They Were in Treatment, Bad
   Things Would Happen, Like Losing Their Job, Home, or Children		 -- 34.6 -- * -- 37.1
Not Ready to Start Treatment -- 61.1 -- * -- 63.4
Not Ready to Stop or Cut Back Using Alcohol or Drugs -- 52.2 -- * -- 53.3
Thought They Should Have Been Able to Handle Their Alcohol
   or Drug Use on Their Own		 -- 74.7 -- * -- 78.6
Thought Their Family, Friends, or Religious Group Would Not
   Like It if They Got Treatment		 -- 16.6 -- * -- 17.8
Thought They Would Be Forced to Stay in Rehab or Treatment
   against Their Will		 -- 23.5 -- * -- 25.8
Did Not Think Treatment Would Help Them -- 26.4 -- * -- 27.6
Thought No One Would Care if They Got Better -- 17.9 -- * -- 19.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment.
NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Respondents could indicate multiple reasons for not receiving substance use treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving substance use treatment data were excluded.
NOTE: Respondents with unknown information for whether they sought or thought they should get substance use treatment were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022.

Go to Top of PageGo to the Table of Contents